TWI805645B - Curable resin composition and manufacturing method thereof - Google Patents
Curable resin composition and manufacturing method thereof Download PDFInfo
- Publication number
- TWI805645B TWI805645B TW107140140A TW107140140A TWI805645B TW I805645 B TWI805645 B TW I805645B TW 107140140 A TW107140140 A TW 107140140A TW 107140140 A TW107140140 A TW 107140140A TW I805645 B TWI805645 B TW I805645B
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- compound
- curable resin
- isocyanate
- resin composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/4007—Curing agents not provided for by the groups C08G59/42 - C08G59/66
- C08G59/4014—Nitrogen containing compounds
- C08G59/4028—Isocyanates; Thioisocyanates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/58—Epoxy resins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/50—Amines
- C08G59/56—Amines together with other curing agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/10—Materials in mouldable or extrudable form for sealing or packing joints or covers
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1339—Gaskets; Spacers; Sealing of cells
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nonlinear Science (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mathematical Physics (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epoxy Resins (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Liquid Crystal (AREA)
- Sealing Material Composition (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
本發明係一種保存安定性、硬化性及洗淨性優異之硬化性樹脂組成物,且包含硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C),前述潛在性硬化劑(B)之一部分或全部與異氰酸酯化合物(C)之一部分或全部可進行反應,前述潛在性硬化劑(B)係選自下列所成之群之至少1種:(b1)卡巴肼(carbazide)化合物、(b2)對環氧樹脂加成咪唑化合物的化合物、(b3)對選自環氧樹脂、異氰酸酯化合物及脲所成之群之至少1種化合物加成多元胺化合物的化合物(但,(b3)中之多元胺化合物不包含聯胺、醯肼化合物及(b1)卡巴肼化合物)、(b4) 2種以上之醯肼化合物之混合結晶、(b5) 1種以上之單或多元胺化合物與1種以上之醯肼化合物之混合結晶,及(b6) 1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶。The present invention is a curable resin composition excellent in storage stability, curability, and cleanability, and includes a curable resin (A), a latent hardener (B) and an isocyanate compound (C). The aforementioned latent hardener Part or all of (B) can react with part or all of the isocyanate compound (C), and the aforementioned latent hardener (B) is at least one selected from the following group: (b1) carbazide (carbazide) Compounds, (b2) compounds in which imidazole compounds are added to epoxy resins, (b3) compounds in which polyamine compounds are added to at least one compound selected from the group consisting of epoxy resins, isocyanate compounds, and urea (however, ( The polyamine compounds in b3) do not include hydrazine compounds, hydrazide compounds and (b1) carbazide compounds), (b4) mixed crystals of two or more hydrazide compounds, and (b5) one or more mono- or polyamine compounds Mixed crystals with one or more hydrazide compounds, and (b6) mixed crystals with one or more imidazole compounds and one or more hydrazide compounds.
Description
本發明尤其有關可較好地使用於液晶顯示器等之液晶顯示元件的硬化性樹脂組成物。In particular, the present invention relates to curable resin compositions that can be preferably used in liquid crystal display elements such as liquid crystal displays.
液晶顯示單元之製造方法有如下方法:於形成於一基材上的密封劑的壩內側滴下液晶後,貼合另一基材而製造液晶顯示單元之方法,或於塗佈密封劑時設置成為注入口之部分,貼合基材後注入液晶,隨後密封注入口而製造液晶顯示單元之方法。由於貼合包含藉由加熱進行之步驟,故作為用以製造液晶顯示單元的密封劑組成物,係使用包含作為加熱硬化成分的含有環氧基之樹脂的熱硬化型樹脂組成物。The manufacturing method of the liquid crystal display unit includes the following methods: After dropping the liquid crystal inside the dam of the sealant formed on one base material, the method of laminating another base material to manufacture the liquid crystal display unit, or setting it as The injection port part is a method of manufacturing a liquid crystal display unit by laminating the base material, injecting liquid crystal, and then sealing the injection port. Since bonding includes a step of heating, a thermosetting resin composition containing an epoxy group-containing resin as a heat-curing component is used as a sealant composition for manufacturing a liquid crystal display unit.
作為該含有環氧基之樹脂之硬化劑,係使用藉由施加熱、光、壓力等而可與環氧基等反應之潛在性硬化劑而進行(專利文獻1、專利文獻2、專利文獻3)。 專利文獻2中,揭示硬化性樹脂組成物,其含有將環氧基及/或聚氰酸酯改質胺的微粉末以水、聚異氰酸酯及環氧樹脂之反應物進行表面處理之潛在性硬化劑。 專利文獻3中,揭示包含藉由具有異氰酸酯基之化合物被覆之醯肼系硬化劑之液晶滴下工法用密封劑。 [先前技術文獻] [專利文獻]As a curing agent for the epoxy group-containing resin, a latent curing agent capable of reacting with epoxy groups or the like by applying heat, light, pressure, etc. is used (Patent Document 1, Patent Document 2, Patent Document 3 ). In Patent Document 2, a curable resin composition is disclosed, which contains a latent hardening method in which fine powders of epoxy groups and/or polycyanate-modified amines are surface-treated with water, polyisocyanate, and epoxy resin reactants. agent. Patent Document 3 discloses a sealing compound for a liquid crystal dropping method including a hydrazine-based curing agent coated with a compound having an isocyanate group. [Prior Art Literature] [Patent Document]
[專利文獻1] 日本特開2001-133794號公報 [專利文獻2] 日本特開2010-90295號公報 [專利文獻3] 日本特開2012-93582號公報[Patent Document 1] Japanese Patent Laid-Open No. 2001-133794 [Patent Document 2] Japanese Unexamined Patent Publication No. 2010-90295 [Patent Document 3] Japanese Patent Laid-Open No. 2012-93582
[發明欲解決之課題][Problem to be solved by the invention]
專利文獻1中,由於使用低溫硬化之硬化劑時,即使於室溫亦緩慢開始硬化反應,故有液安定性變差的問題。 專利文獻2所記載之與異氰酸酯化合物反應之潛在性硬化劑,必須在與硬化性樹脂混合之前預先製造。 專利文獻3中,雖已確認組成物之保存安定性,但針對硬化性並未確認。且密封劑組成物通常係填充於針筒中,塗佈於基材上,並以丙酮等有機溶劑洗淨針筒而重複使用之情況,若使用環氧加成系硬化劑則有洗淨性變差的問題。 因此,本發明之課題在於提供保存安定性、硬化性及洗淨性優異之硬化性樹脂組成物。 [用以解決課題之手段]In Patent Document 1, when a curing agent that is cured at low temperature is used, the curing reaction starts slowly even at room temperature, so there is a problem that the liquid stability is deteriorated. The latent curing agent that reacts with the isocyanate compound described in Patent Document 2 must be prepared in advance before being mixed with the curable resin. In Patent Document 3, although the storage stability of the composition has been confirmed, the curability has not been confirmed. And the sealant composition is usually filled in the syringe, coated on the substrate, and the syringe is washed with an organic solvent such as acetone and reused. If the epoxy addition hardener is used, the cleaning performance will change. bad question. Therefore, an object of the present invention is to provide a curable resin composition excellent in storage stability, curability, and cleanability. [Means to solve the problem]
本發明具有以下構成。 [1] 一種硬化性樹脂組成物,其係包含硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)之硬化性樹脂組成物, 前述潛在性硬化劑(B)之一部分或全部與異氰酸酯化合物(C)之一部分或全部可進行反應, 前述潛在性硬化劑(B)係選自下列所成之群之至少1種:(b1)卡巴肼(carbazide)化合物、(b2)對環氧樹脂加成咪唑化合物的化合物、(b3)對選自環氧樹脂、異氰酸酯化合物及脲所成之群之至少1種化合物加成多元胺化合物的化合物(但,(b3)中之多元胺化合物不包含聯胺、醯肼化合物及(b1)卡巴肼化合物)、(b4) 2種以上之醯肼化合物之混合結晶、(b5) 1種以上之單或多元胺化合物與1種以上之醯肼化合物之混合結晶,及(b6) 1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶。 [2] 如[1]之硬化性樹脂組成物,其中相對於潛在性硬化劑(B) 100質量份,異氰酸酯化合物(C)含有0.02~28質量份。 [3] 如[1]或[2]之硬化性樹脂組成物,其中進而包含光起始劑(D)。 [4] 如[1]至[3]中任一項之硬化性樹脂組成物,其係液晶顯示元件用密封劑組成物。 [5] 一種硬化性樹脂組成物之製造方法,其係包含硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)之硬化性樹脂組成物的製造方法,且包含 不使潛在性硬化劑(B)及異氰酸酯化合物(C)預先反應,而將硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)混合之步驟,且 前述潛在性硬化劑(B)係選自下列所成之群之至少1種:(b1)卡巴肼(carbazide)化合物、(b2)對環氧樹脂加成咪唑化合物的化合物、(b3)對選自環氧樹脂、異氰酸酯化合物及脲所成之群之至少1種化合物加成多元胺化合物的化合物(但,(b3)中之多元胺化合物不包含聯胺、醯肼化合物及(b1)卡巴肼化合物)、(b4) 2種以上之醯肼化合物之混合結晶、(b5) 1種以上之單或多元胺化合物與1種以上之醯肼化合物之混合結晶,及(b6) 1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶。 [6] 一種液晶顯示面板,其係使用如[1]至[4]中任一項之硬化性樹脂組成物而得。 [7] 一種液晶顯示面板之製造方法,其係於液晶滴下工法中,使用如[1]至[4]中任一項之硬化性樹脂組成物,進行光硬化及/或熱硬化。 [發明效果]The present invention has the following constitutions. [1] A curable resin composition comprising a curable resin (A), a latent hardener (B) and an isocyanate compound (C), A part or all of the aforementioned latent hardener (B) can react with a part or all of the isocyanate compound (C), The aforementioned latent hardener (B) is at least one selected from the group consisting of (b1) carbazide (carbazide) compounds, (b2) compounds added to epoxy resins with imidazole compounds, (b3) optional A compound in which a polyamine compound is added to at least one compound of the group consisting of an epoxy resin, an isocyanate compound, and a urea (however, the polyamine compound in (b3) does not include hydrazine, hydrazine compound, and (b1) carbazide compound), (b4) mixed crystals of 2 or more hydrazide compounds, (b5) mixed crystals of 1 or more mono- or polyamine compounds and 1 or more hydrazide compounds, and (b6) 1 or more imidazoles Mixed crystals of a compound and one or more hydrazine compounds. [2] The curable resin composition according to [1], wherein the isocyanate compound (C) is contained in an amount of 0.02 to 28 parts by mass based on 100 parts by mass of the latent curing agent (B). [3] The curable resin composition according to [1] or [2], further comprising a photoinitiator (D). [4] The curable resin composition according to any one of [1] to [3], which is a sealant composition for liquid crystal display elements. [5] A method for producing a curable resin composition, which is a method for producing a curable resin composition comprising a curable resin (A), a latent hardener (B) and an isocyanate compound (C), comprising A step of mixing the curable resin (A), the latent hardener (B) and the isocyanate compound (C) without pre-reacting the latent hardener (B) and the isocyanate compound (C), and The aforementioned latent hardener (B) is at least one selected from the group consisting of (b1) carbazide (carbazide) compounds, (b2) compounds added to epoxy resins with imidazole compounds, (b3) optional A compound in which a polyamine compound is added to at least one compound of the group consisting of an epoxy resin, an isocyanate compound, and a urea (however, the polyamine compound in (b3) does not include hydrazine, hydrazine compound, and (b1) carbazide compound), (b4) mixed crystals of 2 or more hydrazide compounds, (b5) mixed crystals of 1 or more mono- or polyamine compounds and 1 or more hydrazide compounds, and (b6) 1 or more imidazoles Mixed crystals of a compound and one or more hydrazine compounds. [6] A liquid crystal display panel obtained by using the curable resin composition according to any one of [1] to [4]. [7] A method of manufacturing a liquid crystal display panel, which comprises photocuring and/or thermosetting using the curable resin composition according to any one of [1] to [4] in a liquid crystal dropping method. [Invention effect]
本發明之硬化性樹脂組成物之保存安定性及硬化性及洗淨性優異。The curable resin composition of the present invention is excellent in storage stability, curability, and cleanability.
硬化性樹脂組成物係包含硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)之硬化性樹脂組成物, 前述潛在性硬化劑(B)之一部分或全部與異氰酸酯化合物(C)之一部分或全部可進行反應, 前述潛在性硬化劑(B)係選自下列所成之群之至少1種:卡巴肼化合物、對環氧樹脂加成咪唑化合物的化合物、對選自環氧樹脂、異氰酸酯化合物及脲所成之群之至少1種化合物加成多元胺化合物的化合物、2種以上之醯肼化合物之混合結晶、1種以上之多元胺化合物與1種以上之醯肼化合物之混合結晶,及1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶。The curable resin composition is a curable resin composition comprising a curable resin (A), a latent hardener (B) and an isocyanate compound (C), A part or all of the aforementioned latent hardener (B) can react with a part or all of the isocyanate compound (C), The aforementioned latent hardener (B) is at least one selected from the group consisting of carbazide compounds, compounds added to epoxy resins with imidazole compounds, compounds selected from epoxy resins, isocyanate compounds, and urea compounds. Compounds of polyamine compounds added to at least one compound of the group, mixed crystals of two or more kinds of hydrazide compounds, mixed crystals of one or more kinds of polyamine compounds and one or more kinds of hydrazide compounds, and one or more kinds of imidazoles Mixed crystals of a compound and one or more hydrazine compounds.
1.硬化性樹脂(A) 作為硬化性樹脂,舉例為環氧樹脂及分子内具有至少1個不飽和鍵的樹脂(但具有不飽和鍵之環氧樹脂除外)。1. Hardening resin (A) Examples of the curable resin include epoxy resins and resins having at least one unsaturated bond in the molecule (excluding epoxy resins having an unsaturated bond).
[環氧樹脂] 作為環氧樹脂,可使用習知者,舉例為例如雙酚A型環氧樹脂、雙酚F型環氧樹脂、雙酚AD型環氧樹脂、酚酚醛清漆型環氧樹脂、甲酚酚醛青漆型環氧樹脂、環狀脂肪族環氧樹脂、縮水甘油酯系樹脂、縮水甘油胺系環氧樹脂、雜環式環氧樹脂、胺基甲酸酯改質環氧樹脂。該等中,較好使用雙酚A型環氧樹脂、甲酚酚醛青漆型環氧樹脂。[epoxy resin] As the epoxy resin, those known in the art can be used, such as bisphenol A type epoxy resin, bisphenol F type epoxy resin, bisphenol AD type epoxy resin, phenol novolac type epoxy resin, cresol novolak Lacquer type epoxy resin, cycloaliphatic epoxy resin, glycidyl ester resin, glycidyl amine epoxy resin, heterocyclic epoxy resin, urethane modified epoxy resin. Among them, bisphenol A type epoxy resin and cresol novolak type epoxy resin are preferably used.
又,環氧樹脂亦可為具有不飽和鍵之環氧樹脂。作為此等具有不飽和鍵之環氧樹脂,舉例為使環氧樹脂與(甲基)丙烯酸反應所得之環氧基之一部分經(甲基)丙烯酸改質之部分酯化環氧樹脂。作為此等樹脂記載於例如日本特開2012-77202號公報。作為具有不飽和鍵之環氧樹脂較好為對於環氧樹脂之環氧基1當量與(甲基)丙烯酸以10~90當量%,更好20~80當量%,又更好30~70當量%,特佳40~60當量%之(甲基)丙烯酸反應而得之部分酯化環氧樹脂。 環氧樹脂可單獨使用1種,亦可併用複數種。In addition, the epoxy resin may be an epoxy resin having an unsaturated bond. Such an epoxy resin having an unsaturated bond is exemplified by a partially esterified epoxy resin in which a part of epoxy groups obtained by reacting an epoxy resin with (meth)acrylic acid is modified with (meth)acrylic acid. Such resins are described in, for example, JP-A-2012-77202. As an epoxy resin having an unsaturated bond, it is preferably 10-90 equivalent % to 1 equivalent of epoxy group of epoxy resin and (meth)acrylic acid, more preferably 20-80 equivalent %, and more preferably 30-70 equivalent % %, particularly preferably a partially esterified epoxy resin obtained by reacting 40-60 equivalent % of (meth)acrylic acid. An epoxy resin may be used individually by 1 type, and may use plural types together.
部分酯化環氧樹脂可藉由例如首先使雙酚A型環氧樹脂與丙烯酸或甲基丙烯酸依據常用方法在鹼性觸媒存在下,以對於環氧基2當量反應羧酸基為0.9~1.1當量之方式反應,對該反應生成物添加質量比約4倍之甲苯及同量的水,於60~80℃攪拌1小時後,靜置,分離為有機層與水層,去除水層。該操作重複3~5次,最後回收有基層且殘存之甲苯藉由真空蒸餾去除,將水可溶離子性物質經減低化處理之部分酯化環氧樹脂予以純化之方法而獲得。作為上述雙酚A型環氧樹脂之具體例舉例為例如EPICOTE 828、834、1001、1004(三菱化學公司製)、EPICLON 850、860、4055(DIC公司製)等。作為該等原料樹脂較好為經進行水可溶離子性物質減低化處理(亦稱為「高純度化處理」)之樹脂,例如EPICLON 850S(DIC公司製)等。又,作為部分酯化環氧樹脂之例舉例為PR-850CRP(KSM公司製)。Partially esterified epoxy resin can be obtained by, for example, firstly making bisphenol A type epoxy resin and acrylic acid or methacrylic acid in the presence of an alkaline catalyst according to a common method, to react carboxylic acid groups with 2 equivalents of epoxy groups at 0.9~ 1. Reaction in the form of 1 equivalent, add about 4 times the mass ratio of toluene and the same amount of water to the reaction product, stir at 60~80°C for 1 hour, let it stand, separate into an organic layer and an aqueous layer, and remove the aqueous layer. This operation is repeated 3 to 5 times, and finally the base layer is recovered and the remaining toluene is removed by vacuum distillation, and the water-soluble ionic substances are purified by a partially esterified epoxy resin that has been reduced. As a specific example of the said bisphenol-A type epoxy resin, Epicote 828, 834, 1001, 1004 (made by Mitsubishi Chemical Corporation), Epiclon 850, 860, 4055 (made by DIC Corporation), etc. are mentioned, for example. Such raw material resins are preferably resins subjected to water-soluble ionic substance reduction treatment (also referred to as "high-purification treatment"), such as EPICLON 850S (manufactured by DIC Corporation). Moreover, as an example of a partial esterification epoxy resin, PR-850CRP (made by KSM company) is mentioned.
[分子內具有至少1個不飽和鍵之樹脂] 樹脂組成物亦可包含分子內具有至少1個不飽和鍵之樹脂(但具有不飽和鍵之環氧樹脂除外)。作為分子內具有至少1個不飽和鍵之樹脂舉例為苯乙烯衍生物、乙烯衍生物、馬來醯亞胺衍生物、(甲基)丙烯酸衍生物等。其中,較好使用分子內具有至少1個(甲基)丙烯醯基之(甲基)丙烯酸衍生物。[Resins having at least one unsaturated bond in the molecule] The resin composition may also contain a resin having at least one unsaturated bond in the molecule (except epoxy resin having an unsaturated bond). Examples of the resin having at least one unsaturated bond in the molecule include styrene derivatives, vinyl derivatives, maleimide derivatives, (meth)acrylic acid derivatives, and the like. Among them, a (meth)acrylic acid derivative having at least one (meth)acryl group in the molecule is preferably used.
作為(甲基)丙烯酸衍生物具體而言舉例為(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸異丁酯、(甲基)丙烯酸第三丁酯等之(甲基)丙烯酸烷酯;(甲基)丙烯酸苯酯等之(甲基)丙烯酸芳酯;(甲基)丙烯酸苄酯等之(甲基)丙烯酸芳烷酯;(甲基)丙烯酸甲氧基乙酯、(甲基)丙烯酸乙氧乙酯、(甲基)丙烯酸丙氧基丙酯、(甲基)丙烯酸丁氧基乙酯等之(甲基)丙烯酸烷氧基烷酯;(甲基)丙烯酸2-羥基乙酯、(甲基)丙烯酸3-羥基丙酯、(甲基)丙烯酸2-羥基丙酯、(甲基)丙烯酸4-羥基丁酯等之含有羥基之(甲基)丙烯酸酯;如(甲基)丙烯酸環己酯之脂環式醇的(甲基)丙烯酸酯;具有縮水甘油基之樹脂以(甲基)丙烯酸改質之環氧基(甲基)丙烯酸(亦稱為「環氧基(甲基)丙烯酸酯」)等。本說明書中所謂(甲基)丙烯酸意指丙烯酸與甲基丙烯酸兩者。Specific examples of (meth)acrylic acid derivatives include methyl (meth)acrylate, ethyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, (meth)acrylate, ) Alkyl (meth)acrylates such as tert-butyl acrylate; Aryl (meth)acrylates such as phenyl (meth)acrylate; Aralkyl (meth)acrylates such as benzyl (meth)acrylate (meth)acrylic acid such as methoxyethyl (meth)acrylate, ethoxyethyl (meth)acrylate, propoxypropyl (meth)acrylate, butoxyethyl (meth)acrylate, etc. Alkoxyalkyl esters; 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, etc. Hydroxyl-containing (meth)acrylates; (meth)acrylates of alicyclic alcohols such as (meth)cyclohexyl acrylate; resins with glycidyl groups modified with (meth)acrylic acid (meth)acrylic acid (also known as "epoxy (meth)acrylate"), etc. The (meth)acrylic acid used in this specification means both acrylic acid and methacrylic acid.
併用環氧樹脂與分子內具有至少1個不飽和鍵之樹脂時,環氧樹脂與分子內具有至少1個不飽和鍵之樹脂之調配量,可對應於使樹脂組成物硬化之硬化物目的而適當決定。分子內具有至少1個不飽和鍵之樹脂為分子內具有至少1個(甲基)丙烯醯基之(甲基)丙烯酸衍生物時,對於環氧基1當量,較好(甲基)丙烯醯基調配為0.1~9.0當量,更好(甲基)丙烯醯基調配為0.3~4.0當量。When an epoxy resin and a resin having at least one unsaturated bond in the molecule are used together, the blending amount of the epoxy resin and the resin having at least one unsaturated bond in the molecule can be adjusted according to the purpose of hardening the resin composition. Appropriate decision. When the resin with at least one unsaturated bond in the molecule is a (meth)acrylic acid derivative with at least one (meth)acryl group in the molecule, for 1 equivalent of epoxy group, preferably (meth)acryl 0.1-9.0 equivalents for the base, more preferably 0.3-4.0 equivalents for the (meth)acryloyl group.
2.潛在性硬化劑(B) 潛在性硬化劑(B)係選自下列所成之群之至少1種:(b1)卡巴肼化合物、(b2)對環氧樹脂加成咪唑化合物的化合物、(b3)對選自環氧樹脂、異氰酸酯化合物及脲所成之群之至少1種化合物加成多元胺化合物的化合物、(b4) 2種以上之醯肼化合物之混合結晶、(b5) 1種以上之多元胺化合物與1種以上之醯肼化合物之混合結晶,及(b6) 1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶。又,(b3)對自環氧樹脂、異氰酸酯化合物及脲所成之群選出之至少1種化合物加成多元胺化合物的化合物中,多元胺化合物為不包含聯胺、醯肼化合物及(b1)卡巴肼化合物者。2. Latent hardener (B) The latent hardener (B) is at least one selected from the following group: (b1) a carbazide compound, (b2) a compound in which an imidazole compound is added to an epoxy resin, (b3) a compound selected from an epoxy resin , a compound in which at least one compound of the group consisting of isocyanate compound and urea is added to a polyamine compound, (b4) a mixed crystal of two or more hydrazine compounds, (b5) one or more polyamine compounds and one or more (b6) Mixed crystals of one or more imidazole compounds and one or more hydrazine compounds. In addition, in (b3) a compound in which a polyamine compound is added to at least one compound selected from the group consisting of epoxy resins, isocyanate compounds, and urea, the polyamine compound does not include hydrazine compounds and (b1) Carbazide compounds.
[(b1)卡巴肼化合物] 作為卡巴肼化合物舉例為以下述式(Ib)表示之二半卡巴肼化合物及下述式(IIb)表示之半卡巴肼化合物。 (式中,X1 為C1 ~C12 伸烷基、經1個或1個以上之O原子(氧原子)非連續中斷之C2 ~C12 伸烷基、C1 ~C12 伸烷基氧基羰基伸烷基、C3 ~C12 伸環烷基、C1 ~C12 伸烷基-C3 ~C12 伸環烷基、C1 ~C12 伸烷基-C3 ~C12 伸環烷基-C1 ~C12 伸烷基、C3 ~C12 伸環烷基-C1 ~C12 伸烷基-C3 ~C12 伸環烷基、二- C3 ~C12 環烷二基、C6 ~C14 伸芳基、C1 ~C4 伸烷基-C6 ~C14 伸芳基-C1 ~C4 伸烷基、或C6 ~C14 伸芳基-C1 ~C4 伸烷基-C6 ~C14 伸芳基(此處,伸烷基為直鏈或分支鏈,且可經鹵素取代,C3 ~C12 伸環烷基或C6 ~C14 伸芳基可未經取代或可經鹵素或C1 -C4 烷基取代))。 (式中,X2 為C1 ~C12 烷基、經1個或1個以上之O原子(氧原子)非連續中斷之C2 ~C12 烷基、C1 ~C12 烷基氧基羰基伸烷基、C3 ~C12 環烷基、C1 ~C12 烷基-C3 ~C12 環烷基、C3 ~C12 環烷基-C1 ~C12 伸烷基-C3 ~C12 伸環烷基、C6 ~C14 芳基、C1 ~C4 烷基-C6 ~C14 伸芳基、C6 ~C14 芳基-C1 ~C4 伸烷基-C6 ~C14 伸芳基(此處,伸烷基為直鏈或分支鏈,且可經鹵素取代,C3 ~C12 環烷基、C3 ~C12 伸環烷基、C6 ~C14 芳基或C6 ~C14 伸芳基可未經取代或可經鹵素或C1 -C4 烷基取代)或(甲基)丙烯醯氧基烷基)。[(b1) Carbazide Compound] Examples of the carbazide compound include a bisemicarbazide compound represented by the following formula (Ib) and a hemicarbazide compound represented by the following formula (IIb). (In the formula, X 1 is a C 1 ~C 12 alkylene group, a C 2 ~C 12 alkylene group, a C 1 ~C 12 alkylene group interrupted by one or more O atoms (oxygen atoms) discontinuously Oxycarbonylalkylene , C 3 ~ C 12cycloalkylene, C 1 ~C 12alkylene -C 3 ~C 12cycloalkylene, C 1 ~C 12alkylene -C 3 ~C 12 cycloalkylene-C 1 ~C 12 alkylene, C 3 ~C 12 cycloalkylene-C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkylene, di-C 3 ~C 12 cycloalkanediyl, C 6 ~C 14 aryl, C 1 ~C 4 aryl-C 6 ~C 14 aryl-C 1 ~C 4 aryl, or C 6 ~C 14 aryl -C 1 ~C 4 alkylene group -C 6 ~C 14 arylylene group (herein, the alkylene group is straight chain or branched chain, and can be substituted by halogen, C 3 ~C 12 cycloalkylene group or C The 6 -C 14 aryl group may be unsubstituted or may be substituted by halogen or C 1 -C 4 alkyl)). (In the formula, X 2 is a C 1 ~C 12 alkyl group, a C 2 ~C 12 alkyl group, a C 1 ~C 12 alkyloxy group interrupted by one or more O atoms (oxygen atoms) discontinuously Carbonyl alkylene, C 3 ~C 12 cycloalkyl, C 1 ~C 12 alkyl-C 3 ~C 12 cycloalkyl, C 3 ~C 12 cycloalkyl-C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkylene, C 6 ~C 14 aryl, C 1 ~C 4 alkyl-C 6 ~C 14 aryl, C 6 ~C 14 aryl-C 1 ~C 4 alkylene -C 6 ~C 14 aryl (here, the alkyl is straight chain or branched, and can be substituted by halogen, C 3 ~C 12 cycloalkyl, C 3 ~C 12 cycloalkyl, C 6 ~C 14 aryl or C 6 ~C 14 aryl can be unsubstituted or can be substituted by halogen or C 1 -C 4 alkyl) or (meth)acryloxyalkyl).
本說明書中,單獨或與其他用語的組合中,「C1 ~C12 烷基」係直鏈或分支鏈者,亦可經鹵素取代,亦可1個或1個以上之O原子(氧原子)非連續中斷,較好為直鏈者。烷基之碳數範圍舉例為C1 ~C12 ,更好為C1 ~C8 ,又更好為C1 ~C6 ,特佳為C1 ~C4 之範圍。作為其具體例,舉例為例如甲基、乙基、正丙基、正丁基、正戊基、正己基、正庚基、正辛基、正壬基、正癸基、正十一烷基、正十二烷基等之直鏈者,異丙基、異丁基、第二丁基、第三丁基、2-甲基丁基、異辛基、第三辛基、2-乙基己基、第三壬基等之分支鏈者。作為鹵素舉例為氟原子、氯原子、溴原子及碘原子。作為取代基之鹵素較好為氟原子或氯原子,更好為氟原子。取代數為1~12個,較好1~6個,更好1~4個,特佳為1~3個。In this specification, alone or in combination with other terms, "C 1 ~C 12 alkyl" is a straight chain or branched chain, which may also be substituted by halogen, or one or more O atoms (oxygen atom ) is non-continuously interrupted, preferably a straight chain. The carbon number range of the alkyl group is, for example, C 1 ~C 12 , more preferably C 1 ~C 8 , even more preferably C 1 ~C 6 , especially preferably C 1 ~C 4 . Specific examples thereof include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl , n-dodecyl and other straight chains, isopropyl, isobutyl, second butyl, third butyl, 2-methylbutyl, isooctyl, third octyl, 2-ethyl Branched chains of hexyl, third nonyl, etc. Examples of the halogen include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. The halogen as a substituent is preferably a fluorine atom or a chlorine atom, more preferably a fluorine atom. The number of substitutions is 1-12, preferably 1-6, more preferably 1-4, particularly preferably 1-3.
本說明書中,單獨或與其他用語的組合中,「C1 ~C12 伸烷基」係直鏈或分支鏈者,亦可經鹵素取代,亦可1個或1個以上之NH(亞胺基)或O原子(氧原子)非連續中斷(鍵結於N原子(氮原子)之H原子(氫原子)可經胺基或C1 ~C12 烷基胺基取代),較好為直鏈者。伸烷基之碳數範圍舉例為C1 ~C12 ,更好為C1 ~C8 ,又更好為C1 ~C6 ,特佳為C1 ~C4 之範圍。作為其具體例,舉例為例如亞甲基、伸乙基、三亞甲基、伸丙基、四亞甲基、1-甲基三亞甲基、2-甲基三亞甲基、3-甲基三亞甲基、五亞甲基、1-甲基四亞甲基、4-甲基四亞甲基、六亞甲基、5-甲基五亞甲基、七亞甲基、八亞甲基、九亞甲基、十亞甲基、十一亞甲基、十二亞甲基等。作為鹵素舉例為氟原子、氯原子、溴原子及碘原子。作為取代基之鹵素較好為氟原子或氯原子,更好為氟原子。取代數為1~12個,較好1~6個,更好1~4個,特佳為1~3個。In this specification, alone or in combination with other terms, "C 1 ~C 12 alkylene" is a straight chain or branched chain, and may be substituted by halogen, or one or more NH (imine) group) or O atom (oxygen atom) non-continuously interrupted (H atom (hydrogen atom) bonded to N atom (nitrogen atom) can be substituted by amino group or C 1 ~C 12 alkylamine group), preferably straight chain. The carbon number range of the alkylene group is, for example, C 1 ~C 12 , more preferably C 1 ~C 8 , even more preferably C 1 ~C 6 , especially preferably C 1 ~C 4 . Specific examples thereof include methylene, ethylene, trimethylene, propylene, tetramethylene, 1-methyltrimethylene, 2-methyltrimethylene, 3-methyltrimethylene Methyl, pentamethylene, 1-methyltetramethylene, 4-methyltetramethylene, hexamethylene, 5-methylpentamethylene, heptamethylene, octamethylene, Nonamethylene, Decamethylene, Undecamethylene, Dodecamethylene, etc. Examples of the halogen include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. The halogen as a substituent is preferably a fluorine atom or a chlorine atom, more preferably a fluorine atom. The number of substitutions is 1-12, preferably 1-6, more preferably 1-4, particularly preferably 1-3.
本說明書中,「C1 ~C12 烷基氧基羰基伸烷基」或「C1 ~C12 伸烷基氧基羰基伸烷基」之烷基氧基或伸烷基氧基之碳數範圍舉例為C1 ~C12 ,更好為C1 ~C8 ,又更好為C1 ~C6 ,特佳為C1 ~C4 之範圍。作為其具體例,舉例為例如甲氧基羰基亞甲基、乙氧基羰基亞甲基、正丙氧基羰基亞甲基、正丁氧基羰基亞甲基、正戊氧基羰基亞甲基、正己氧基羰基亞甲基、正庚氧基羰基亞甲基、正辛氧基羰基亞甲基、正壬氧基羰基亞甲基、正癸氧基羰基亞甲基、正十一烷氧基羰基亞甲基、正十二烷氧基羰基亞甲基等之直鏈者,異丙氧基羰基亞甲基、異丁氧基羰基亞甲基、第二丁氧基羰基亞甲基、第三丁氧基羰基亞甲基、2-甲基丁氧基羰基亞甲基、異辛氧基羰基亞甲基、第三辛氧基羰基亞甲基、2-乙基己氧基羰基亞甲基等之分支鏈者。In this specification, the carbon number of the alkyloxy or alkyleneoxy group of "C 1 ~C 12 alkyloxycarbonylalkylene" or "C 1 ~C 12 alkyleneoxycarbonylalkylene" The range is, for example, C 1 ~C 12 , more preferably C 1 ~C 8 , more preferably C 1 ~C 6 , particularly preferably C 1 ~C 4 . Specific examples thereof include, for example, methoxycarbonylmethylene, ethoxycarbonylmethylene, n-propoxycarbonylmethylene, n-butoxycarbonylmethylene, n-pentoxycarbonylmethylene , n-hexyloxycarbonylmethylene, n-heptyloxycarbonylmethylene, n-octyloxycarbonylmethylene, n-nonyloxycarbonylmethylene, n-decyloxycarbonylmethylene, n-undecyloxy Straight chains such as ylcarbonylmethylene, n-dodecyloxycarbonylmethylene, isopropoxycarbonylmethylene, isobutoxycarbonylmethylene, second butoxycarbonylmethylene, 3-butoxycarbonylmethylene, 2-methylbutoxycarbonylmethylene, isooctyloxycarbonylmethylene, 3-octyloxycarbonylmethylene, 2-ethylhexyloxycarbonylmethylene Branched chains such as methyl groups.
本說明書中,單獨或與其他用語的組合中,「C3 ~C12 環烷基」之碳數範圍舉例為C3 ~C12 ,更好為C3 ~C8 ,又更好為C3 ~C6 ,特佳為C4 ~C6 之範圍。作為其具體例,舉例為例如環丙基、環丁基、環戊基、環己基、環庚基、環辛基、環壬基、環癸基、環十一烷基及環十二烷基。C3 ~C12 環烷基較好為環戊基或環己基。C3 ~C12 環烷基為未經取代或可經鹵素或C1 ~C4 烷基取代,作為鹵素舉例為氟原子、氯原子、溴原子及碘原子。作為取代基之鹵素較好為氟原子或氯原子,更好為氯原子。作為取代基之C1 ~C4 烷基舉例為甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基及第三丁基。作為取代基之C1 ~C4 烷基較好為甲基、乙基或正丙基,更好為甲基或乙基。具有取代基時之取代數為1~5個,較好1~3個,更好1~2個,特佳為1個。In this specification, alone or in combination with other terms, the carbon number range of "C 3 ~C 12 cycloalkyl" is for example C 3 ~C 12 , more preferably C 3 ~C 8 , and more preferably C 3 ~C 6 , particularly preferably in the range of C 4 ~C 6 . Specific examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, and cyclododecyl . C 3 -C 12 cycloalkyl is preferably cyclopentyl or cyclohexyl. C 3 -C 12 cycloalkyl is unsubstituted or may be substituted by halogen or C 1 -C 4 alkyl, examples of halogen include fluorine atom, chlorine atom, bromine atom and iodine atom. The halogen as a substituent is preferably a fluorine atom or a chlorine atom, more preferably a chlorine atom. Examples of C 1 -C 4 alkyl groups as substituents include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second-butyl and third-butyl. The C 1 -C 4 alkyl as a substituent is preferably methyl, ethyl or n-propyl, more preferably methyl or ethyl. When having a substituent, the number of substitutions is 1 to 5, preferably 1 to 3, more preferably 1 to 2, most preferably 1.
本說明書中,單獨或與其他用語的組合中,「C3 ~C12 伸環烷基」之碳數範圍舉例為C3 ~C12 ,更好為C3 ~C8 ,又更好為C3 ~C6 ,特佳為C4 ~C6 之範圍。作為其具體例,舉例為例如伸環丙基、伸環丁基、伸環戊基、伸環己基、伸環庚基、伸環辛基、伸環壬基、伸環癸基、伸環十一烷基及伸環十二烷基。C3 ~C12 伸環烷基較好為伸環戊基或伸環己基。C3 ~C12 伸環烷基為未經取代或可經鹵素或C1 ~C4 烷基取代,作為鹵素舉例為氟原子、氯原子、溴原子及碘原子。作為取代基之鹵素較好為氟原子或氯原子,更好為氯原子。作為取代基之C1 ~C4 烷基舉例為甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基及第三丁基。作為取代基之C1 ~C4 烷基較好為甲基、乙基或正丙基,更好為甲基或乙基。具有取代基時之取代數為1~4個,較好1~3個,更好1~2個,特佳為1個。In this specification, alone or in combination with other terms, the carbon number range of "C 3 ~ C 12 cycloalkylene" is for example C 3 ~C 12 , more preferably C 3 ~C 8 , and more preferably C 3 ~C 6 , particularly preferably in the range of C 4 ~C 6 . Specific examples thereof include cyclopropyl, cyclobutylene, cyclopentylene, cyclohexylene, cycloheptylene, cyclooctylene, cyclononyl, cyclodecylene, cyclodecylene Monoalkyl and cyclododecyl. The C 3 -C 12 cycloalkylene group is preferably a cyclopentylene group or a cyclohexylene group. The C 3 -C 12 cycloalkylene group is unsubstituted or may be substituted by halogen or C 1 -C 4 alkyl group, and the halogen is exemplified by fluorine atom, chlorine atom, bromine atom and iodine atom. The halogen as a substituent is preferably a fluorine atom or a chlorine atom, more preferably a chlorine atom. Examples of C 1 -C 4 alkyl groups as substituents include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second-butyl and third-butyl. The C 1 -C 4 alkyl as a substituent is preferably methyl, ethyl or n-propyl, more preferably methyl or ethyl. When having a substituent, the number of substitutions is 1 to 4, preferably 1 to 3, more preferably 1 to 2, particularly preferably 1.
本說明書中,單獨或與其他用語的組合中,「C6 ~C14 芳基」係具有至少1個芳香族環之1價基。作為其具體例,舉例為例如苯基、聯苯基、萘基、蒽基、菲基等。較好為苯基、聯苯基或萘基,更好為苯基或萘基。C6 ~C14 芳基為未經取代或可經鹵素或C1 ~C4 烷基取代,作為鹵素舉例為氟原子、氯原子、溴原子及碘原子。作為取代基之鹵素較好為氟原子或氯原子,更好為氯原子。作為取代基之C1 ~C4 烷基舉例為甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基及第三丁基。作為取代基之C1 ~C4 烷基較好為甲基、乙基或正丙基,更好為甲基或乙基。具有取代基時之取代數為1~5個,較好1~3個,更好1~2個,特佳為1個。In this specification, "C 6 -C 14 aryl" is a monovalent group having at least one aromatic ring alone or in combination with other terms. Specific examples thereof include, for example, phenyl, biphenyl, naphthyl, anthracenyl, and phenanthrenyl. Preferably it is phenyl, biphenyl or naphthyl, more preferably phenyl or naphthyl. The C 6 -C 14 aryl group is unsubstituted or may be substituted by a halogen or a C 1 -C 4 alkyl group, and the halogen is exemplified by a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. The halogen as a substituent is preferably a fluorine atom or a chlorine atom, more preferably a chlorine atom. Examples of C 1 -C 4 alkyl groups as substituents include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second-butyl and third-butyl. The C 1 -C 4 alkyl as a substituent is preferably methyl, ethyl or n-propyl, more preferably methyl or ethyl. When having a substituent, the number of substitutions is 1 to 5, preferably 1 to 3, more preferably 1 to 2, particularly preferably 1.
本說明書中,單獨或與其他用語的組合中,「C6 ~C14 伸芳基」係具有至少1個芳香族環之2價基。作為其具體例,舉例為例如伸苯基、伸萘基、伸蒽基、伸菲基等。較好為伸苯基、伸萘基,更好為伸苯基或伸萘基。C6 ~C14 伸芳基為未經取代或可經鹵素或C1 ~C4 烷基取代,作為鹵素舉例為氟原子、氯原子、溴原子及碘原子。作為取代基之鹵素較好為氟原子、氯原子或溴原子,更好為氟原子或氯原子。作為取代基之C1 ~C4 烷基舉例為甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基及第三丁基。作為取代基之C1 ~C4 烷基較好為甲基、乙基或正丙基,更好為甲基或乙基。具有取代基時之取代數為1~4個,較好1~3個,更好1~2個,特佳為1個。In this specification, "C 6 -C 14 arylenyl" is a divalent group having at least one aromatic ring alone or in combination with other terms. Specific examples thereof include, for example, phenylene, naphthylene, anthracenyl, and phenanthrene. Preferably it is a phenylene group and a naphthylene group, More preferably, it is a phenylene group or a naphthylene group. The C 6 -C 14 aryl group is unsubstituted or may be substituted by halogen or C 1 -C 4 alkyl, and the halogen is exemplified by fluorine atom, chlorine atom, bromine atom and iodine atom. The halogen as a substituent is preferably a fluorine atom, a chlorine atom or a bromine atom, more preferably a fluorine atom or a chlorine atom. Examples of C 1 -C 4 alkyl groups as substituents include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second-butyl and third-butyl. The C 1 -C 4 alkyl as a substituent is preferably methyl, ethyl or n-propyl, more preferably methyl or ethyl. When having a substituent, the number of substitutions is 1 to 4, preferably 1 to 3, more preferably 1 to 2, particularly preferably 1.
[(b2)對環氧樹脂加成咪唑化合物的化合物] 咪唑化合物係分子內不具有1級胺基之咪唑化合物,作為此等咪唑化合物,舉例為包含1位的氮原子未經取代之咪唑環的化合物例如2-甲基咪唑、2-十一烷基咪唑、2-十八烷基咪唑、2-乙基-4-甲基咪唑、2-苯基咪唑、2-苯基-4-甲基咪唑、2-苯基咪唑異氰尿酸加成物、2-苯基-4,5-二羥基甲基咪唑、2-苯基-4-甲基-5-羥基甲基咪唑級2-甲基咪唑啉;以及包含1位的氮原子經取代之咪唑環的化合物例如1,2-二甲基咪唑、1-苄基-2-甲基咪唑、1-苄基-2-苯基咪唑、1-氰基乙基-2-甲基咪唑、1-氰基乙基-2-苯基咪唑、1-氰基乙基-2-十一烷基咪唑鎓苯偏三酸酯及1-氰基乙基-2-苯基咪唑鎓苯偏三酸酯等。 作為對環氧樹脂加成咪唑化合物的化合物中之環氧樹脂舉例為於硬化性樹脂(A)中例示者。 作為對環氧樹脂加成咪唑化合物的化合物的市售品舉例為EH-5011S(ADEKA股份有限公司製)、FXR-1121(T&K TOKA股份有限公司製)。[(b2) A compound in which an imidazole compound is added to an epoxy resin] The imidazole compound is an imidazole compound that does not have a primary amino group in the molecule. Examples of such imidazole compounds include compounds containing an imidazole ring with an unsubstituted nitrogen atom at the 1-position, such as 2-methylimidazole, 2-undecyl Imidazole, 2-octadecylimidazole, 2-ethyl-4-methylimidazole, 2-phenylimidazole, 2-phenyl-4-methylimidazole, 2-phenylimidazole isocyanuric acid adduct, 2-phenyl-4,5-dihydroxymethylimidazole, 2-phenyl-4-methyl-5-hydroxymethylimidazole grade 2-methylimidazoline; and imidazoles containing substituted nitrogen atoms at position 1 Cyclic compounds such as 1,2-dimethylimidazole, 1-benzyl-2-methylimidazole, 1-benzyl-2-phenylimidazole, 1-cyanoethyl-2-methylimidazole, 1- Cyanoethyl-2-phenylimidazole, 1-cyanoethyl-2-undecylimidazolium trimellitate and 1-cyanoethyl-2-phenylimidazolium trimellitate wait. The epoxy resin among the compounds to which an imidazole compound is added to an epoxy resin is exemplified in curable resin (A). EH-5011S (made by ADEKA Co., Ltd.) and FXR-1121 (made by T&K TOKA Co., Ltd.) are mentioned as a commercial item of the compound which added the imidazole compound to an epoxy resin.
[(b3)對選自環氧樹脂、異氰酸酯化合物及脲所成之群選出之至少1種化合物加成多元胺化合物的化合物] (多元胺化合物) 多元胺化合物係具有至少2個1級胺基之化合物,且舉例為具有2個1級胺基之二胺化合物、具有3個1級胺基之三胺化合物等。[(b3) A compound in which a polyamine compound is added to at least one compound selected from the group consisting of epoxy resins, isocyanate compounds, and urea] (polyamine compound) The polyamine compound is a compound having at least 2 primary amine groups, and is exemplified by a diamine compound having 2 primary amine groups, a triamine compound having 3 primary amine groups, and the like.
(具有2個1級胺基之二胺化合物) 作為具有2個1級胺基之二胺化合物並未特別限定,但舉例為例如脂肪族二胺、脂環族二胺、芳香族二胺等。又,作為具有2個1級胺基之二胺化合物的具體例,舉例為下述式(5a)表示之多元胺化合物。(diamine compound with 2 primary amine groups) Although it does not specifically limit as a diamine compound which has two primary amino groups, For example, aliphatic diamine, alicyclic diamine, aromatic diamine etc. are mentioned. Moreover, as a specific example of the diamine compound which has two primary amino groups, the polyamine compound represented by following formula (5a) is mentioned.
式中,L為C1 ~C12 伸烷基、經1個或1個以上之NH(亞胺基)或O原子(氧原子)非連續中斷之C2 ~C12 伸烷基(鍵結於N原子(氮原子)之H原子(氫原子)可經胺基或C1 ~C12 烷基胺基取代)、C3 ~C12 伸環烷基、C1 ~C12 伸烷基-C3 ~C12 伸環烷基、C1 ~C12 伸烷基-C3 ~C12 伸環烷基-C1 ~C12 伸烷基、C3 ~C12 伸環烷基-C1 ~C4 伸烷基-C3 ~C12 伸環烷基、C6 ~C14 伸芳基、C1 ~C4 伸烷基-C6 ~C14 伸芳基、C1 ~C4 伸烷基-C6 ~C14 伸芳基-C1 ~C4 伸烷基、或C6 ~C14 伸芳基-C1 ~C4 伸烷基-C6 ~C14 伸芳基(此處,伸烷基為直鏈或分支鏈,且可經鹵素取代,C3 ~C12 伸環烷基或C6 ~C14 伸芳基可未經取代或可經鹵素或C1 -C4 烷基取代) In the formula, L is a C 1 ~C 12 alkylene group, a C 2 ~C 12 alkylene group (bonding group) interrupted non-continuously by one or more NH (imino groups) or O atoms (oxygen atoms). The H atom (hydrogen atom) of the N atom (nitrogen atom) can be replaced by an amino group or a C 1 ~C 12 alkylamino group), a C 3 ~C 12 cycloalkylene group, a C 1 ~C 12 alkylene group- C 3 ~C 12 cycloalkylene, C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkylene-C 1 ~C 12 alkylene, C 3 ~C 12 cycloalkylene-C 1 ~C 4 alkylene-C 3 ~C 12 cycloalkylene, C 6 ~C 14 aryl, C 1 ~C 4 alkylene-C 6 ~C 14 aryl, C 1 ~C 4 Alkyl-C 6 ~C 14 aryl-C 1 ~C 4 aryl, or C 6 ~C 14 aryl-C 1 ~C 4 aryl-C 6 ~C 14 aryl (this , the alkylene group is straight or branched and can be substituted by halogen, and the C 3 ~C 12 cycloalkylene group or C 6 ~C 14 arylylene group can be unsubstituted or can be substituted by halogen or C 1 -C 4 Alkyl substitution)
芳香族二胺中,作為式(5a)中L為C1 ~C12 伸烷基的化合物,具體舉例為例如乙二胺、丙二胺、1,2-二胺基丙烷、1,3-二胺基丙烷、1,3-二胺基丁烷、四亞甲基二胺、五亞甲基二胺、六亞甲基二胺、七亞甲基二胺、八亞甲基二胺、十二亞甲基二胺、丙烷-1,2-二胺、1,2-二胺基-2-甲基丙烷等。Among the aromatic diamines, as the compound in which L is a C 1 ~C 12 alkylene group in the formula (5a), specific examples include ethylenediamine, propylenediamine, 1,2-diaminopropane, 1,3- Diaminopropane, 1,3-diaminobutane, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, heptamethylenediamine, octamethylenediamine, Dodecamethylenediamine, propane-1,2-diamine, 1,2-diamino-2-methylpropane, etc.
芳香族二胺中,作為式(5a)中L為經1個或1個以上的O原子(氧原子)非連續地中斷之直鏈或分支鏈的C1 ~C12 伸烷基的化合物,具體舉例為例如2,2’-氧基雙(乙基胺)、1,2-雙(2-胺基乙氧基)乙烷、1,11-二胺基-3,6,9-三氧雜十一烷、雙(3-胺基丙基)醚、1,4-丁二醇雙(3-胺基丙基)醚、二乙二醇雙(3-胺基丙基)醚、乙二醇雙(3-胺基丙基)醚等。Among the aromatic diamines, as a compound in which L in the formula (5a) is a linear or branched C1 - C12 alkylene compound discontinuously interrupted by one or more O atoms (oxygen atoms), Specific examples include, for example, 2,2'-oxybis(ethylamine), 1,2-bis(2-aminoethoxy)ethane, 1,11-diamino-3,6,9-tri Oxaundecane, bis(3-aminopropyl) ether, 1,4-butanediol bis(3-aminopropyl) ether, diethylene glycol bis(3-aminopropyl) ether, Ethylene glycol bis(3-aminopropyl) ether, etc.
芳香族二胺中,作為式(5a)中L為經1個或1個以上的NH(醯亞胺基)非連續地中斷之直鏈或分支鏈的C2 ~C12 伸烷基(鍵結於N原子(氮原子)之H原子(氫原子)可經胺基或C1 ~C12 烷基胺基取代)的化合物,具體舉例為例如二伸乙三胺、三伸乙四胺、四伸乙五胺、五伸乙六胺、三(2-胺基乙基)胺、N,N’-雙(3-胺基丙基)乙二胺、雙(六亞甲基)三胺、3,3’-二胺基-N-甲基二丙胺、3,3’-二胺基二丙胺、雙(3-胺基丙基)甲胺等。Among the aromatic diamines, as in the formula (5a), L is a linear or branched C 2 ~C 12 alkylene (bond) discontinuously interrupted by one or more NH (imide groups) The H atom (hydrogen atom) bonded to the N atom (nitrogen atom) can be replaced by an amine group or a C 1 ~C 12 alkylamine group), specifically exemplified such as diethylenetriamine, triethylenetetramine, Tetraethylenepentamine, Pentaethylenehexamine, Tris(2-aminoethyl)amine, N,N'-bis(3-aminopropyl)ethylenediamine, bis(hexamethylene)triamine , 3,3'-diamino-N-methyldipropylamine, 3,3'-diaminodipropylamine, bis(3-aminopropyl)methylamine, etc.
作為脂環族二胺具體舉例為例如異冰片二胺、1,4-二胺基環己烷、1,3-二胺基環己烷、反式-1,2-二胺基環己烷、1,3-雙(胺基甲基)環己烷、4,4’-亞甲基雙(環己基胺)、1,4-二胺基-3,6-二乙基環己烷、異冰片二胺等。Specific examples of alicyclic diamines include isobornyl diamine, 1,4-diaminocyclohexane, 1,3-diaminocyclohexane, trans-1,2-diaminocyclohexane , 1,3-bis(aminomethyl)cyclohexane, 4,4'-methylenebis(cyclohexylamine), 1,4-diamino-3,6-diethylcyclohexane, Isobornyl diamine, etc.
作為芳香族二胺具體舉例為例如對-苯二胺、間-苯二胺、鄰-二甲苯二胺、對-二甲苯二胺、間-二甲苯二胺、4,4’-二胺基二苯基甲烷、1,5-二胺基萘、1,8-二胺基萘、2,6-二胺基甲苯、2,4-二胺基-6-[2’-甲基咪唑啉基-(1’)]-乙基-s-三嗪、2,4-二胺基-6-[2’-十一烷基咪唑啉基-(1’)]-乙基-s-三嗪、2,4-二胺基-6-[2’-乙基-4’-甲基咪唑啉基-(1’)]-乙基-s-三嗪、2,4-二胺基-6-[2’-甲基咪唑啉基-(1’)]-乙基-s-三嗪、異氰脲酸加成物等之具有1位的氮原子經取代之咪唑啉基之1級二胺、二胺基二苯基碸等。Specific examples of aromatic diamines include, for example, p-phenylenediamine, m-phenylenediamine, o-xylylenediamine, p-xylylenediamine, m-xylylenediamine, 4,4'-diamine Diphenylmethane, 1,5-diaminonaphthalene, 1,8-diaminonaphthalene, 2,6-diaminotoluene, 2,4-diamino-6-[2'-methylimidazoline Base-(1')]-ethyl-s-triazine, 2,4-diamino-6-[2'-undecylimidazolinyl-(1')]-ethyl-s-triazine oxazine, 2,4-diamino-6-[2'-ethyl-4'-methylimidazolinyl-(1')]-ethyl-s-triazine, 2,4-diamino- 6-[2'-Methylimidazolinyl-(1')]-ethyl-s-triazine, isocyanuric acid adducts, etc., the 1st grade of imidazolinyl substituted with a nitrogen atom at the 1-position Diamine, diaminodiphenylsulfone, etc.
作為具有3個1級胺基之三胺化合物具體舉例為例如三(4-胺基苯基)胺、三(3-胺基丙基)胺、以下述式表示之三(2-胺基乙基)胺、二伸乙三胺、三伸乙三胺、四伸乙三胺、四伸乙五胺等之多烷基多胺等。 Specific examples of triamine compounds having three primary amine groups include tris(4-aminophenyl)amine, tris(3-aminopropyl)amine, tris(2-aminoethyl) represented by the following formula base) amine, diethylenetriamine, triethylenetriamine, tetraethylenetriamine, tetraethylenepentamine and other polyalkylene polyamines.
(b3)中之多元胺化合物不包含聯胺(NH2 NH2 )、醯肼化合物及(b1)卡巴肼化合物。(b3)中之多元胺化合物較好不包含具有聯胺基(NH2 NH-)之化合物。此處,醯肼化合物舉例為後述之醯肼化合物中例示者。又,(b3)以外之多元胺化合物包含聯胺、醯肼化合物及(b1)卡巴肼化合物。然而,(b3)以外之多元胺化合物亦可包含聯胺、醯肼化合物及(b1)卡巴肼化合物。The polyamine compound in (b3) does not include hydrazine (NH 2 NH 2 ), hydrazide compound and (b1) carbazide compound. The polyamine compound in (b3) preferably does not contain a compound having a hydrazine group (NH 2 NH—). Here, the hydrazide compound is exemplified by the hydrazide compound described later. In addition, polyamine compounds other than (b3) include hydrazine compounds, hydrazide compounds, and (b1) carbazide compounds. However, the polyamine compound other than (b3) may also include hydrazine, hydrazide compound and (b1) carbazide compound.
(環氧樹脂) 作為對環氧樹脂加成多元胺化合物的化合物中之環氧樹脂舉例為硬化性樹脂(A)中例示者。(epoxy resin) As an epoxy resin in the compound which added the polyamine compound to an epoxy resin, what was illustrated in curable resin (A) is mentioned.
(異氰酸酯化合物) 作為對異氰酸酯化合物加成多元胺化合物的化合物中之異氰酸酯化合物舉例為後述之異氰酸酯化合物(C)中例示者。(isocyanate compound) As an isocyanate compound in the compound which added the polyamine compound to an isocyanate compound, what was illustrated in the isocyanate compound (C) mentioned later is mentioned.
作為多元胺化合物與環氧樹脂之加成化合物的市售品舉例為EH-5001P、EH-4370S、EH-5015S、EH-4375S、EH-5030S、EH-5057P、EH-4358S(以上為ADEKA股份有限公司製)、FXR-1020、FXR-1030、FXR-1081(以上為T&K TOKA股份有限公司製)。Examples of commercially available products that are addition compounds of polyamine compounds and epoxy resins are EH-5001P, EH-4370S, EH-5015S, EH-4375S, EH-5030S, EH-5057P, and EH-4358S (the above are ADEKA shares Co., Ltd.), FXR-1020, FXR-1030, FXR-1081 (the above are made by T&K TOKA Co., Ltd.).
(較佳態樣) 基於更提高與硬化性樹脂(A)之反應性,可更縮短硬化時間之觀點,作為(b3)對自環氧樹脂、異氰酸酯化合物及脲所成之群選出之至少1種化合物加成多元胺化合物的化合物較好為對異氰酸酯化合物加成多元胺化合物的化合物。(better form) From the viewpoint of further improving the reactivity with the curable resin (A) and shortening the curing time, as (b3) adding a polyamine to at least one compound selected from the group consisting of epoxy resins, isocyanate compounds, and urea The compound is preferably a compound obtained by adding a polyamine compound to an isocyanate compound.
[(b4) 2種以上之醯肼化合物之混合結晶、(b5) 1種以上之單或多元胺化合物與1種以上之醯肼化合物之混合結晶,及(b6) 1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶] 2種以上之醯肼化合物之混合結晶、1種以上之單或多元胺化合物與1種以上之醯肼化合物之混合結晶、以及1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶係具有與混合結晶中所含之單獨成分的結晶系不同結晶系的混合結晶。混合結晶之X射線繞射光譜與混合結晶中所含之原料的1種單體或多元胺化合物之X射線繞射光譜比較,藉由確認存在源自原料的峰以外的峰而可確認混合結晶之存在。 作為該等混合結晶中之醯肼化合物舉例為後述醯肼化合物中例示者。 作為(b5) 1種以上之單或多元胺化合物與1種以上之醯肼化合物之混合結晶中之多元胺化合物,舉例為於(b3)對自環氧樹脂、異氰酸酯化合物及脲所成之群選出之至少1種化合物加成多元胺化合物的化合物中例示者。 作為(b6) 1種以上之咪唑化合物與1種以上之醯肼化合物之混合結晶,舉例為(b2)對環氧樹脂加成咪唑化合物的化合物中例示者。[(b4) Mixed crystals of 2 or more hydrazide compounds, (b5) Mixed crystals of 1 or more mono- or polyamine compounds and 1 or more hydrazide compounds, and (b6) 1 or more imidazole compounds and Mixed crystal of more than one hydrazine compound] Mixed crystals of two or more hydrazide compounds, mixed crystals of one or more mono- or polyamine compounds and one or more hydrazide compounds, and mixed crystals of one or more imidazole compounds and one or more hydrazide compounds It is a mixed crystal having a crystal system different from that of the individual components contained in the mixed crystal. Mixed crystals can be identified by comparing the X-ray diffraction spectrum of the mixed crystal with the X-ray diffraction spectrum of a single monomer or polyamine compound contained in the raw material contained in the mixed crystal, and confirming the presence of peaks other than those derived from the raw material existence. Examples of the hydrazide compound in these mixed crystals include those exemplified in the hydrazide compound described later. As the polyamine compound in the mixed crystal of (b5) one or more kinds of mono- or polyamine compounds and one or more kinds of hydrazine compounds, for example, the group formed from epoxy resin, isocyanate compound and urea in (b3) Examples are those in which at least one selected compound is added to a polyamine compound. Examples of (b6) mixed crystals of one or more imidazole compounds and one or more hydrazide compounds are those exemplified in (b2) Compounds in which imidazole compounds are added to epoxy resins.
(醯肼化合物) 作為醯肼化合物舉例為分子內具有1個醯肼基之一元酸醯肼、分子內具有2個醯肼基之二元酸醯肼、分子內具有3個醯肼基之三元酸醯肼、分子內具有4個以上醯肼基之多官能醯肼。(hydrazine compound) Examples of the hydrazine compound include hydrazine monobasic acid having one hydrazine group in the molecule, hydrazine dibasic acid having 2 hydrazine groups in the molecule, hydrazine tribasic acid having 3 hydrazine groups in the molecule, Polyfunctional hydrazines with more than 4 hydrazine groups in the molecule.
作為一元酸醯肼具體舉例為乙醯肼、丙酸醯肼、戊酸醯肼、月桂酸醯肼、環己烷甲醯肼、水楊酸醯肼、對-羥基苯甲酸醯肼、萘甲酸醯肼、苯磺醯肼。Specific examples of monobasic acid hydrazide include acetylhydrazine, propionate, valerate, laurate, cyclohexane hydrazine, salicylic acid hydrazide, p-hydroxybenzoic acid hydrazide, and naphthoic acid. Hydrazine, benzenesulfonylhydrazine.
作為二元酸醯肼具體舉例為草酸二醯肼、丙二酸二醯肼、琥珀酸二醯肼、己二酸二醯肼、庚二酸二醯肼、辛二酸二醯肼、壬二酸二醯肼、癸二酸二醯肼、十二烷酸二醯肼、十六烷酸二醯肼、間苯二甲酸二醯肼、對苯二甲酸二醯肼、甲醯肼、馬來酸二醯肼、富馬酸二醯肼、二乙醇酸二醯肼、酒石酸二醯肼、蘋果酸二醯肼、2,6-萘甲酸二醯肼、1,4-萘甲酸二醯肼、4,4’-雙苯二醯肼、氫醌二乙醇酸二醯肼、間苯二酚二乙醇酸二醯肼、兒茶酚二乙醇酸二醯肼、4,4’-亞乙基雙酚二乙醇酸二醯肼、4,4’-亞乙烯基雙酚二乙醇酸二醯肼等。Specific examples of dihydrazide dibasic acid include dihydrazide oxalate, dihydrazide malonate, dihydrazide succinate, dihydrazide adipate, dihydrazide pimelate, dihydrazide suberate, azelaic acid, Dihydrazine sebacate, dihydrazine sebacate, dihydrazine dodecanoate, dihydrazine hexadecanoate, dihydrazide isophthalate, dihydrazine terephthalate, formhydrazine, maleic acid Dihydrazine acid, Dihydrazine fumarate, Dihydrazine diglycolate, Dihydrazine tartrate, Dihydrazine malate, Dihydrazine 2,6-naphthoate, Dihydrazine 1,4-naphthoate, 4,4'-diphenylhydrazine, diglycolic acid dihydrazine hydroquinone, resorcinol diglycolic acid dihydrazine, catechol diglycolic acid dihydrazine, 4,4'-ethylene diglycolic acid dihydrazine Phenol diglycolic acid dihydrazide, 4,4'-vinylidene bisphenol diglycolic acid dihydrazide, etc.
作為三元酸醯肼舉例為例如1,3,5-三(2-肼羰基乙基)異氰脲酸酯等之1,3,5-三(2-肼羰基烷基)異氰脲酸酯等。 作為多官能醯肼舉例為例如聚丙烯酸醯肼等。Examples of hydrazine tribasic acid include 1,3,5-tris(2-hydrazinecarbonylalkyl)isocyanurate such as 1,3,5-tris(2-hydrazinecarbonylethyl)isocyanurate Esters etc. As polyfunctional hydrazine, polyacrylic acid hydrazine etc. are mentioned, for example.
又,醯肼化合物係2種以上醯肼化合物之組合時,較好醯肼化合物之至少1種為二元酸二醯肼,尤其更佳為所有醯肼化合物為二元酸二醯肼。作為所有醯肼化合物為二元酸二醯肼的醯肼化合物之組合,可舉例為例如己二酸二醯肼與癸二酸二醯肼、己二酸二醯肼與癸二酸二醯肼、癸二酸二醯肼與癸二酸二醯肼、癸二酸二醯肼與十二烷二酸二醯肼之組合等,更好為癸二酸二醯肼與十二烷二酸二醯肼之組合。Also, when the hydrazine compound is a combination of two or more hydrazine compounds, it is preferable that at least one of the hydrazine compounds is a dibasic acid dihydrazide, and it is especially more preferable that all the hydrazine compounds are dibasic acid dihydrazides. As a combination of hydrazine compounds in which all the hydrazine compounds are dibasic acid dihydrazides, for example, adipate dihydrazide and sebacic acid dihydrazide, adipate dihydrazide and sebacate dihydrazide , dihydrazide sebacic acid and dihydrazine sebacate, dihydrazine sebacate and dihydrazine dodecanedioic acid, etc., more preferably dihydrazine sebacate and dihydrazine A combination of hydrazines.
2種以上之醯肼化合物之混合結晶於利用CuKα射線之X射線繞射光譜中之布拉格角(2θ±0.2°)之20~25°之間觀察到2~3根左右的強繞射峰的結晶變態。又,混合結晶中所用之醯肼化合物較好為結晶性醯肼化合物。此處,結晶性醯肼化合物意指於對於CuKα射線(波長1.541Å之X射線繞射光譜中,於布拉格角度2θ(誤差2θ±0.2°)之5.0~7.5°之範圍具有波峰之醯肼化合物。Mixed crystals of two or more hydrazine compounds have about 2-3 strong diffraction peaks observed between 20-25° of the Bragg angle (2θ±0.2°) in the X-ray diffraction spectrum using CuKα rays Crystal metamorphosis. Also, the hydrazine compound used in the mixed crystallization is preferably a crystalline hydrazine compound. Here, the crystalline hydrazide compound means a hydrazide compound having a peak in the range of 5.0 to 7.5° of the Bragg angle 2θ (error 2θ±0.2°) in the X-ray diffraction spectrum with respect to CuKα rays (wavelength 1.541Å) .
(混合結晶之組成等) 混合結晶中所用之單或多元胺化合物、咪唑化合物及/或醯肼化合物之併用比例,可對應於欲硬化之環氧樹脂種類、用途、所要求之硬化時間或硬化溫度等之各種條件適當決定。例如宜以使全部混合結晶中之1種化合物通常含有1~99重量%,較好10~90重量%,更好30~70重量%之方式併用2種以上之化合物。(composition of mixed crystals, etc.) The combination ratio of mono- or polyamine compound, imidazole compound and/or hydrazine compound used in the mixed crystallization can be appropriately determined according to various conditions such as the type of epoxy resin to be cured, the application, the required curing time or curing temperature, etc. . For example, it is preferable to use two or more compounds in combination so that one compound in all mixed crystals contains usually 1 to 99% by weight, preferably 10 to 90% by weight, more preferably 30 to 70% by weight.
(混合結晶中進而含有之成分) 混合結晶可進而包含可與混合結晶所含之化合物形成錯合物之金屬元素。由於包含金屬元素之混合結晶可進而提高液安定性之改善效果故而較佳。較好為包含2種以上之醯肼化合物的混合結晶可與該2種以上之醯肼化合物的混合結晶中之醯肼化合物形成錯合物之金屬元素的2種以上醯肼化合物的混合結晶。(Constituents further contained in mixed crystals) The mixed crystal may further contain a metal element that can form a complex with a compound contained in the mixed crystal. It is preferable because mixed crystals containing metal elements can further enhance the effect of improving the stability of the liquid. It is preferably a mixed crystal of two or more hydrazide compounds containing a metal element that can form a complex with the hydrazide compound in the mixed crystal of two or more hydrazide compounds.
作為金屬元素較好舉例為自鋁、鈦、錫、鋯、鋅、鐵、鎂、鈷、鎳、鉍、鉬、銅、銻、鋇、硼、錳、銦、銫、鈥、釔、矽、鈣、銀、鎘及金所成之群組中選擇之至少1種。作為金屬元素,更好為自鋁、鈦、錫、鋯、鋅、鐵、鎂、鈷、鎳、鉍、鉬、銅、銻、鋇及硼所成之群組中選擇之至少1種。金屬元素可使用1種或任意組合2種以上而使用。且金屬元素可使用金屬氧化物、金屬氫氧化物之形態者。Preferred examples of metal elements are aluminum, titanium, tin, zirconium, zinc, iron, magnesium, cobalt, nickel, bismuth, molybdenum, copper, antimony, barium, boron, manganese, indium, cesium, yttrium, silicon, At least one selected from the group consisting of calcium, silver, cadmium and gold. The metal element is more preferably at least one selected from the group consisting of aluminum, titanium, tin, zirconium, zinc, iron, magnesium, cobalt, nickel, bismuth, molybdenum, copper, antimony, barium, and boron. Metal elements may be used alone or in any combination of two or more. In addition, metal elements can be used in the form of metal oxides and metal hydroxides.
金屬元素之含量,相對於混合結晶與金屬元素之合計量,較好為0.1~20.0質量%,更好為1.0~10.0質量%。金屬元素之含量,相對於混合結晶中所含之化合物與金屬元素之合計量,為0.1~20.0質量%時,推測金屬元素與混合結晶中所含之化合物例如結晶性醯肼化合物形成良好錯合物。The content of the metal element is preferably from 0.1 to 20.0% by mass, more preferably from 1.0 to 10.0% by mass, based on the total amount of the mixed crystal and the metal element. When the content of the metal element is 0.1-20.0% by mass relative to the total amount of the compound and the metal element contained in the mixed crystal, it is presumed that the metal element and the compound contained in the mixed crystal, such as a crystalline hydrazine compound, form a good complex thing.
(混合結晶之製造方法) 混合結晶之製造方法係包含下列步驟之方法:將原料的2種以上之胺化合物(亦即2種以上之醯肼化合物之組合、1種以上之單或多元胺化合物與1種以上醯肼化合物之組合、或1種以上咪唑化合物與1種以上醯肼化合物之組合)於熔點以上加熱熔融予以混合,獲得混合物之步驟,以及冷卻該混合物並固化之步驟。具體而言混合結晶之製造方法係包含下列步驟之方法:將自(b4’) 2種以上之醯肼化合物之組合、(b5’) 1種以上之單或多元胺化合物(分子內具有1個以上1級胺基之1級單、二及多胺化合物、分子內具有1個以上2級胺基之2級單、二及多胺化合物)與1種以上醯肼化合物之組合、以及(b6’) 1種以上咪唑化合物與1種以上醯肼化合物之組合所成之群組選擇之原料的2種以上之胺化合物於熔點以上加熱熔融予以混合,獲得混合物之步驟,以及冷卻該混合物並固化之步驟。(Manufacturing method of mixed crystal) The production method of mixed crystals is a method comprising the following steps: combining two or more amine compounds (that is, a combination of two or more hydrazide compounds, one or more mono- or polyamine compounds and one or more hydrazide compounds) as raw materials or a combination of one or more imidazole compounds and one or more hydrazide compounds) are heated and melted above the melting point and mixed to obtain a mixture, and the mixture is cooled and solidified. Specifically, the method for producing mixed crystals is a method comprising the following steps: combining (b4') two or more hydrazine compounds, (b5') one or more mono- or polyamine compounds (with one Combinations of the above primary mono-, di- and polyamine compounds with primary amine groups, and secondary mono-, di- and polyamine compounds with one or more secondary amine groups in the molecule) and more than one hydrazine compound, and (b6 ') two or more amine compounds selected from a group consisting of a combination of one or more imidazole compounds and one or more hydrazide compounds are heated and melted at a temperature above the melting point, mixed to obtain a mixture, and the mixture is cooled and solidified the steps.
加熱熔融及混合步驟中,加熱原料的2種以上之胺化合物之溫度並未特別限定,但較好為使原料的2種以上之胺化合物的混合物成為大致液體狀態之溫度。作為使原料的2種以上之胺化合物的混合物成為大致液體狀態之溫度,較好為原料的2種以上之胺化合物的熔點附近的溫度,例如自比熔點低10℃左右之溫度至比該熔點高10℃左右的溫度。此處,原料的2種以上之胺化合物的熔點意指原料的2種以上之胺化合物的熔點中熔點最高的溫度。In the heat-melting and mixing step, the temperature at which the two or more amine compounds of the raw materials are heated is not particularly limited, but is preferably a temperature at which the mixture of the two or more amine compounds of the raw materials becomes substantially liquid. The temperature at which the mixture of two or more amine compounds used as raw materials becomes substantially liquid is preferably a temperature near the melting point of the two or more amine compounds used as raw materials, for example, from a temperature about 10°C lower than the melting point to a temperature lower than the melting point. The temperature is about 10°C higher. Here, the melting point of the two or more kinds of amine compounds of the raw material means the temperature at which the melting point is the highest among the melting points of the two or more kinds of amine compounds of the raw material.
使原料的2種以上之胺化合物的熔融混合物冷卻並固化之步驟中之冷卻速度較好為20~0.01℃/分鐘,更好為10~0.05℃/分鐘,進而更好為5~0.1℃/分鐘。冷卻可多階段進行例如以2階段進行。例如可於第一階段冷卻至100~50℃,於該溫度使結晶成長,於第2階段冷卻至室溫。The cooling rate in the step of cooling and solidifying the molten mixture of two or more amine compounds as raw materials is preferably from 20 to 0.01°C/min, more preferably from 10 to 0.05°C/min, still more preferably from 5 to 0.1°C/min. minute. Cooling can be performed in multiple stages, for example, in two stages. For example, it can be cooled to 100-50° C. in the first stage, crystals are grown at this temperature, and cooled to room temperature in the second stage.
又,包含該原料的2種以上之胺化合物之混合結晶與可與原料的胺化合物形成錯合物之金屬的混合結晶之製造方法,包含使單或多元胺化合物、咪唑化合物或醯肼化合物,與可與單或多元胺化合物、咪唑化合物或醯肼化合物形成錯合物之金屬元素加熱熔融並混合,獲得混合物之步驟,及對混合物進行恆溫處理之步驟,以及冷卻混合物獲得固化體之步驟。Also, the method for producing a mixed crystal of two or more amine compounds comprising the raw material and a mixed crystal of a metal capable of forming a complex with the amine compound of the raw material comprises making a mono- or poly-amine compound, an imidazole compound or a hydrazide compound, A step of heating, melting and mixing with a metal element that can form a complex with a mono- or polyamine compound, an imidazole compound or an hydrazide compound to obtain a mixture, a step of constant temperature treatment of the mixture, and a step of cooling the mixture to obtain a solidified body.
關於加熱熔融並混合獲得混合物之步驟及冷卻混合物獲得固化體之步驟係如上述。 對混合物進行恆溫處理之步驟係使混合物於一定時間、一定溫度進行恆溫處理之步驟。所謂恆溫處理意指使混合物於一定溫度(誤差範圍±10℃)保持一定時間。恆溫處理之溫度並未特別限定,較好為100~280℃,更好為130~250℃。恆溫處理之時間並未特別限定,可為配合作為硬化劑使用時之使用目的等而設為最適宜處理時間例如0.01~10小時。The steps of heating, melting and mixing to obtain a mixture and cooling the mixture to obtain a solidified body are as described above. The step of subjecting the mixture to constant temperature treatment is a step of subjecting the mixture to constant temperature treatment at a certain time and temperature. The so-called constant temperature treatment means keeping the mixture at a certain temperature (error range ±10° C.) for a certain period of time. The temperature of the constant temperature treatment is not particularly limited, but is preferably from 100 to 280°C, more preferably from 130 to 250°C. The time for constant temperature treatment is not particularly limited, and it can be set as the most suitable treatment time, for example, 0.01 to 10 hours, in accordance with the purpose of use when used as a hardener.
進而混合結晶之製造方法較好包含將冷卻所得之固化體粉碎,粉碎成平均粒徑為0.1~20.0μm之粒狀的步驟。 作為粉碎之方法,較好使用例如高壓粉碎機粉碎固化體。作為高壓粉碎機,舉例為例如十字噴射研磨機(栗源鐵工所公司製)、逆噴射研磨機(HOSOKAWA MICRO公司製)、乾式噴射粉碎機(Nano Jetmizer)(AISHIN NANO TECHNOLOGY公司製)等。Furthermore, the method for producing mixed crystals preferably includes the step of pulverizing the solidified body obtained by cooling to a granular shape with an average particle diameter of 0.1 to 20.0 μm. As a pulverization method, it is preferable to pulverize the solidified body using, for example, a high-pressure pulverizer. Examples of the high-pressure mill include a cross jet mill (manufactured by Kurimoto Iron Works Co., Ltd.), a reverse jet mill (manufactured by HOSOKAWA MICRO), and a dry jet mill (Nano Jetmizer) (manufactured by AISHIN NANO TECHNOLOGY).
(潛在硬化劑(B)之較佳態樣) 潛在硬化劑(B)較好具有粒狀形態。潛在硬化劑(B)之平均粒徑並未特別限制,但較好為0.1~20.0μm,更好為0.2~10.0μm。又,平均粒徑可藉由利用雷射繞射・散射法之粒度分佈測定裝置求得,平均粒徑係利用雷射繞射・散射法之粒度分佈測定中作為體積平均值D50 (D50 係累積體積成為50%時之粒徑,亦即中值徑)測定之值。具有粒狀形態之潛在硬化劑(B)可藉由粉碎潛在硬化劑(B)而獲得。(Preferable aspect of latent curing agent (B)) The latent curing agent (B) preferably has a granular form. The average particle size of the latent hardener (B) is not particularly limited, but is preferably from 0.1 to 20.0 μm, more preferably from 0.2 to 10.0 μm. In addition, the average particle size can be obtained by a particle size distribution measuring device using the laser diffraction and scattering method, and the average particle size is the volume average value D50 ( D50 It is the measured value of the particle diameter when the cumulative volume becomes 50%, that is, the median diameter). The latent hardener (B) having a granular form can be obtained by pulverizing the latent hardener (B).
3.異氰酸酯化合物(C) 異氰酸酯化合物係至少具有1個異氰酸酯基(-N=C=O)之化合物,並未特別限定,但舉例為單異氰酸酯化合物、二異氰酸酯化合物、三異氰酸酯化合物、四異氰酸酯化合物等。3. Isocyanate compound (C) The isocyanate compound is a compound having at least one isocyanate group (-N=C=O), and is not particularly limited, but examples thereof include monoisocyanate compounds, diisocyanate compounds, triisocyanate compounds, and tetraisocyanate compounds.
(單異氰酸酯化合物) 作為單異氰酸酯化合物,舉例為下述式(1a)表示之化合物。 式(1a)中,X4 為C1 ~C12 烷基、經1個或1個以上之O原子(氧原子)非連續中斷之C2 ~C12 烷基、C1 ~C12 烷基氧基羰基伸烷基、C3 ~C12 環烷基、C1 ~C12 烷基-C3 ~C12 伸環烷基、C3 ~C12 環烷基-C1 ~C12 伸烷基-C3 ~C12 伸環烷基、C6 ~C14 芳基、C1 ~C4 烷基-C6 ~C14 伸芳基、C6 ~C14 芳基-C1 ~C4 伸烷基-C6 ~C14 伸芳基(此處,伸烷基為直鏈或分支鏈,且可經鹵素取代,C3 ~C12 環烷基、C3 ~C12 伸環烷基、C6 ~C14 芳基或C6 ~C14 伸芳基可未經取代或可經鹵素或C1 -C4 烷基取代)或(甲基)丙烯醯氧基烷基。(Monoisocyanate compound) As a monoisocyanate compound, the compound represented by following formula (1a) is mentioned. In formula (1a), X 4 is C 1 ~C 12 alkyl, C 2 ~C 12 alkyl, C 1 ~C 12 alkyl interrupted by one or more O atoms (oxygen atoms) discontinuously Oxycarbonyl alkylene, C 3 ~C 12 cycloalkyl, C 1 ~C 12 alkyl-C 3 ~C 12 cycloalkylene, C 3 ~C 12 cycloalkyl-C 1 ~C 12 alkylene Base-C 3 ~C 12 cycloalkylene, C 6 ~C 14 aryl, C 1 ~C 4 alkyl-C 6 ~C 14 aryl, C 6 ~C 14 aryl-C 1 ~C 4 Alkylene-C 6 ~C 14 arylylene (here, the alkylene is straight chain or branched, and can be substituted by halogen, C 3 ~C 12 cycloalkyl, C 3 ~C 12 cycloalkyl , C 6 ~C 14 aryl or C 6 ~C 14 aryl may be unsubstituted or may be substituted by halogen or C 1 -C 4 alkyl) or (meth)acryloxyalkyl.
作為單異氰酸酯化合物之(甲基)丙烯醯氧基烷基異氰酸酯舉例為下述式(1b)表示之化合物。 式(1b),R6 表示氫原子或甲基,R7 表示C1 ~C6 伸烷基。R7 之C1 ~C6 伸烷基的碳數範圍較好為C2 ~C6 ,更好為C3 ~C6 。The (meth)acryloxyalkyl isocyanate as a monoisocyanate compound is illustrated by the compound represented by following formula (1b). In formula (1b), R 6 represents a hydrogen atom or a methyl group, and R 7 represents a C 1 ~C 6 alkylene group. The carbon number range of the C 1 -C 6 alkylene group of R 7 is preferably C 2 -C 6 , more preferably C 3 -C 6 .
作為單異氰酸酯化合物具體舉例為例如異氰酸甲酯、異氰酸乙酯、異氰酸正己酯、異氰酸環己酯、異氰酸2-乙基己酯、異氰酸苯酯、異氰酸苄酯、異氰酸丙酯、異氰酸異丙酯、異氰酸丁酯、異氰酸戊酯、異氰酸十二烷酯、異氰酸十八烷酯、異氰酸第三丁酯、異氰酸酯基乙酸乙酯、異氰酸酯基乙酸丁酯、(S)-(-)-2-異氰酸酯基丙酸甲酯、異氰酸苯酯、異氰酸1-萘酯、異氰酸4-氯苯酯、異氰酸4-氟苯酯、異氰酸苯乙酯、異氰酸對-甲苯酯、異氰酸間-甲苯酯、異氰酸3,5-二甲基苯酯、異氰酸3-(三乙氧基矽烷基)丙酯等。Specific examples of monoisocyanate compounds include methyl isocyanate, ethyl isocyanate, n-hexyl isocyanate, cyclohexyl isocyanate, 2-ethylhexyl isocyanate, phenyl isocyanate, isocyanate, Benzyl cyanate, propyl isocyanate, isopropyl isocyanate, butyl isocyanate, amyl isocyanate, dodecyl isocyanate, octadecyl isocyanate, isocyanate Tributyl, ethyl isocyanatoacetate, butyl isocyanatoacetate, (S)-(-)-2-methylisocyanatopropionate, phenyl isocyanate, 1-naphthyl isocyanate, isocyanate 4-chlorophenyl ester, 4-fluorophenyl isocyanate, phenylethyl isocyanate, p-cresyl isocyanate, m-cresyl isocyanate, 3,5-dimethylphenyl isocyanate , 3-(triethoxysilyl)propyl isocyanate, etc.
作為(甲基)丙烯醯氧基烷基異氰酸酯具體舉例為例如(甲基)丙烯醯氧基甲基異氰酸酯、(甲基)丙烯醯氧基乙基異氰酸酯、(甲基)丙烯醯氧基丙基異氰酸酯等。Specific examples of (meth)acryloxyalkyl isocyanate include (meth)acryloxymethyl isocyanate, (meth)acryloxyethyl isocyanate, (meth)acryloxypropyl isocyanates, etc.
(二異氰酸酯化合物) 作為二異氰酸酯化合物,舉例為下述式(2a)表示之化合物。 式(2a)中,X5 為C1 ~C12 伸烷基、經1個或1個以上之O原子(氧原子)非連續中斷之C2 ~C12 伸烷基、C1 ~C12 伸烷基氧基羰基伸烷基、C3 ~C12 伸環烷基、C1 ~C12 伸烷基-C3 ~C12 伸環烷基、C1 ~C12 伸烷基-C3 ~C12 伸環烷基-C1 ~C12 伸烷基、C3 ~C12 伸環烷基-C1 ~C12 伸烷基-C3 ~C12 伸環烷基、二- C3 ~C12 環烷二基、C6 ~C14 伸芳基、C1 ~C4 伸烷基-C6 ~C14 伸芳基-C1 ~C4 伸烷基、或C6 ~C14 伸芳基-C1 ~C4 伸烷基-C6 ~C14 伸芳基(此處,伸烷基為直鏈或分支鏈,且可經鹵素取代,C3 ~C12 伸環烷基或C6 ~C14 伸芳基可未經取代或可經鹵素或C1 -C4 烷基取代)。(Diisocyanate compound) As a diisocyanate compound, the compound represented by following formula (2a) is mentioned. In formula (2a), X 5 is a C 1 ~C 12 alkylene group, a C 2 ~C 12 alkylene group interrupted by one or more O atoms (oxygen atoms), C 1 ~C 12 Alkylene oxycarbonyl alkylene, C 3 ~C 12 cycloalkylene, C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkylene, C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkylene- C 1 ~C 12 alkylene, C 3 ~C 12 cycloalkylene-C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkylene, di-C 3 ~C 12 cycloalkanediyl, C 6 ~C 14 aryl, C 1 ~C 4 aryl-C 6 ~C 14 aryl-C 1 ~C 4 aryl, or C 6 ~C 14 Arylylene-C 1 ~C 4 alkylene-C 6 ~C 14 arylylene (here, the alkylene is straight chain or branched, and can be substituted by halogen, C 3 ~C 12 cycloalkylene Or C 6 ~C 14 aryl groups may be unsubstituted or may be substituted by halogen or C 1 -C 4 alkyl).
作為二異氰酸酯化合物具體舉例為例如二苯基甲烷二異氰酸酯(MDI)、甲苯二異氰酸酯(TDI)、二甲苯二異氰酸酯(XDI)、氫化二甲苯二異氰酸酯(氫化XDI)、異佛酮二異氰酸酯(IPDI)、聯甲苯胺二異氰酸酯(TPDI)、六亞甲基二異氰酸酯(HDI)、二環己基甲烷二異氰酸酯(HMDI)、2,4,4-三甲基六亞甲基二異氰酸酯(TMHDI)、3,5,5-三甲基六亞甲基二異氰酸酯(TMHDI)、4,4’-二異氰酸酯基3,3’-二甲基聯苯、4,4’-二異氰酸酯基3,3’-二甲基二苯基甲烷、2,2-雙(4-異氰酸酯基苯基)六氟丙烷、2,4-二異氰酸酯基甲苯、1,3-雙(2-異氰酸酯基2-丙基)苯、甲苯-2,6-二異氰酸酯、1,4-苯二異氰酸酯、1,3-苯二異氰酸酯、1,5-二異氰酸酯基萘等。Specific examples of diisocyanate compounds include, for example, diphenylmethane diisocyanate (MDI), toluene diisocyanate (TDI), xylene diisocyanate (XDI), hydrogenated xylene diisocyanate (hydrogenated XDI), isophorone diisocyanate (IPDI), ), benzylidine diisocyanate (TPDI), hexamethylene diisocyanate (HDI), dicyclohexylmethane diisocyanate (HMDI), 2,4,4-trimethylhexamethylene diisocyanate (TMHDI), 3,5,5-Trimethylhexamethylene diisocyanate (TMHDI), 4,4'-diisocyanate 3,3'-dimethylbiphenyl, 4,4'-diisocyanate 3,3' -Dimethyldiphenylmethane, 2,2-bis(4-isocyanatophenyl)hexafluoropropane, 2,4-diisocyanatotoluene, 1,3-bis(2-isocyanato-2-propyl) Benzene, toluene-2,6-diisocyanate, 1,4-benzenediisocyanate, 1,3-benzenediisocyanate, 1,5-diisocyanatonaphthalene, etc.
(三異氰酸酯化合物) 作為三異氰酸酯化合物舉例為於3末端具有異氰酸酯基之具有異氰脲酸酯構造、縮二脲構造或加成物構造之化合物。作為具有異氰脲酸酯構造之三異氰酸酯化合物舉例為下述式(3a)表示之具有異氰脲酸酯構造之化合物。 式中,R2 為相同或不同,為直鏈或分支鏈的C1 ~C12 伸烷基。(Triisocyanate Compound) As a triisocyanate compound, a compound having an isocyanurate structure, a biuret structure, or an adduct structure having an isocyanate group at the 3 terminal is exemplified. As a triisocyanate compound which has an isocyanurate structure, the compound which has an isocyanurate structure represented by following formula (3a) is mentioned. In the formula, R 2 are the same or different, and are linear or branched C 1 -C 12 alkylene groups.
作為具有縮二脲構造之三異氰酸酯化合物舉例為下述式(3b)表示之化合物。 式中,R3 為相同或不同,為直鏈或分支鏈的C1 ~C12 伸烷基。As a triisocyanate compound which has a biuret structure, the compound represented by following formula (3b) is mentioned. In the formula, R 3 are the same or different, and are linear or branched C 1 -C 12 alkylene groups.
作為具有加成物構造之三異氰酸酯化合物舉例為下述式(3c)表示之化合物。 式中,R4 為相同或不同,為直鏈或分支鏈的C1 ~C12 伸烷基,R5 為CH。Examples of the triisocyanate compound having an adduct structure include compounds represented by the following formula (3c). In the formula, R 4 is the same or different, and is a linear or branched C 1 ~ C 12 alkylene group, and R 5 is CH.
作為三異氰酸酯化合物具體舉例為例如三(異氰酸酯基甲基)異氰脲酸酯、三(異氰酸酯基乙基)異氰脲酸酯、三(異氰酸酯基丙基)異氰脲酸酯、三(異氰酸酯基丁基)異氰脲酸酯、三(異氰酸酯基己基)異氰脲酸酯、N,N’-2-参-異氰酸酯基甲基丙二酸醯胺、N,N’-2-参-異氰酸酯基己基丙二酸醯胺等。Specific examples of the triisocyanate compound include, for example, tris(isocyanatomethyl)isocyanurate, tris(isocyanatoethyl)isocyanurate, tris(isocyanatopropyl)isocyanurate, tris(isocyanate butyl) isocyanurate, tris(isocyanatohexyl) isocyanurate, N,N'-2-paraisocyanatomethylmalonamide, N,N'-2-paraffin- Isocyanatohexylmalonamide, etc.
(四異氰酸酯化合物) 作為四異氰酸酯化合物舉例為自下述式(4a)表示之化合物所衍生之4價基。 式中,X3 為C3 ~C12 環烷基-C1 ~C12 伸烷基-C3 ~C12 環烷基或C6 ~C14 芳基-C1 ~C4 伸烷基-C6 ~C14 芳基(伸烷基為直鏈或分支鏈,且可經鹵素取代,C3 ~C12 環烷基或C6 ~C14 芳基可未經取代或可經鹵素或C1 -C4 烷基取代。(Tetraisocyanate compound) As a tetraisocyanate compound, the tetravalent group derived from the compound represented by following formula (4a) is mentioned. In the formula, X 3 is C 3 ~C 12 cycloalkyl-C 1 ~C 12 alkylene-C 3 ~C 12 cycloalkyl or C 6 ~C 14 aryl-C 1 ~C 4 alkylene- C 6 ~C 14 aryl (alkylene is straight chain or branched, and can be substituted by halogen, C 3 ~C 12 cycloalkyl or C 6 ~C 14 aryl can be unsubstituted or can be substituted by halogen or C 1 -C 4 alkyl substitution.
又,作為四異氰酸酯化合物,舉例為下述式(4b)表示之四異氰酸酯矽烷。 Moreover, tetraisocyanate silane represented by following formula (4b) is mentioned as a tetraisocyanate compound.
作為四異氰酸酯化合物具體舉例為例如4,4’-二苯基甲烷-2,2’,5,5’-四異氰酸酯、四異氰酸酯矽烷等。Specific examples of the tetraisocyanate compound include, for example, 4,4'-diphenylmethane-2,2',5,5'-tetraisocyanate, tetraisocyanate silane, and the like.
4.製造方法 硬化性樹脂組成物之製造方法係包含硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)之硬化性樹脂組成物的製造方法,且包含 不使潛在性硬化劑(B)及異氰酸酯化合物(C)預先反應,而將硬化性樹脂(A)、潛在性硬化劑(B)、異氰酸酯化合物(C)及任意成分混合之步驟。 混合方法可將硬化性樹脂(A)及異氰酸酯化合物(C)攪拌混合後,攪拌混合潛在性硬化劑(B),亦可將硬化性樹脂(A)及潛在性硬化劑(B)攪拌混合後,攪拌混合異氰酸酯化合物(C)。 混合時之溫度為所混合之潛在性硬化劑(B)的熔點附近的溫度或反應活性溫度帶的溫度,則會使硬化性樹脂(A)及潛在性硬化劑(B)反應,故而欠佳。且混合時之溫度過於低溫時,抑制了樹脂流動性而不易攪拌。因此混合時之溫度較好為0~40℃,更好為10~40℃,又更好為20~40℃。4. Manufacturing method A method for producing a curable resin composition is a method for producing a curable resin composition comprising a curable resin (A), a latent hardener (B) and an isocyanate compound (C), and includes A step of mixing the curable resin (A), the latent hardener (B), the isocyanate compound (C) and optional components without previously reacting the latent hardener (B) and the isocyanate compound (C). The mixing method can be to mix the curable resin (A) and the isocyanate compound (C) after stirring and mixing the latent hardener (B), or to mix the curable resin (A) and the latent hardener (B) after stirring , stirring and mixing the isocyanate compound (C). The temperature during mixing is near the melting point of the latent hardener (B) to be mixed or the temperature in the reactive temperature range will cause the hardening resin (A) and latent hardener (B) to react, so it is not good . And when the mixing temperature is too low, the fluidity of the resin is inhibited and it is difficult to stir. Therefore, the temperature during mixing is preferably from 0 to 40°C, more preferably from 10 to 40°C, and still more preferably from 20 to 40°C.
以往的硬化性樹脂組成物之製造方法中,係使潛在性硬化劑及異氰酸酯化合物預先反應,而以異氰酸酯化合物被覆潛在性硬化劑表面者添加於硬化性樹脂組成物中。 然而,本發明中,僅包含將硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)混合之步驟,即可簡便地製造硬化性樹脂組成物。作為其理由認為是由於將硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)混合時,潛在性硬化劑(B)與異氰酸酯化合物(C)之反應性高,故所混合之組成物中,促進潛在性硬化劑表面之胺基與異氰酸酯化合物的反應之故。In the conventional production method of a curable resin composition, a latent hardener and an isocyanate compound are reacted in advance, and the surface of the latent hardener is coated with an isocyanate compound and added to the curable resin composition. However, in the present invention, the curable resin composition can be easily produced only by including the step of mixing the curable resin (A), the latent hardener (B) and the isocyanate compound (C). The reason for this is considered to be that when the curable resin (A), the latent curing agent (B) and the isocyanate compound (C) are mixed, the latent curing agent (B) has a high reactivity with the isocyanate compound (C), so the In the mixed composition, the reaction between the amine group on the surface of the latent hardener and the isocyanate compound is promoted.
5.潛在性硬化劑(B)及異氰酸酯化合物(C)之狀態 如上述,硬化性樹脂組成物係藉由不使潛在性硬化劑(B)及異氰酸酯化合物(C)預先反應,而將硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)混合而製造。如此混合硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C)後,確認到潛在性硬化劑(B)之表面胺基量減少。此處,所謂表面胺基量係指存在於粒狀之潛在性硬化劑(B)之表面或表層的胺基量。因此,潛在性硬化劑(B)之一部分或全部與異氰酸酯化合物(C)之一部分或全部反應。較好潛在性硬化劑(B)之全部與異氰酸酯化合物(C)之全部反應。例如,在潛在性硬化劑(B)之全部反應時,硬化性樹脂組成物中之潛在性硬化劑(B)不含有未反應狀態,但若確認到潛在性硬化劑(B)與異氰酸酯化合物(C)之反應物,則成為本發明之硬化性樹脂組成物。 如此潛在性硬化劑(B)之一部分或全部與異氰酸酯化合物(C)之一部分或全部反應時,潛在性硬化劑(B)表面之至少一部分成為與異氰酸酯化合物(C)反應。亦即,由於潛在性硬化劑(B)與異氰酸酯化合物(C)之反應性高,故認為潛在性硬化劑(B)與異氰酸酯化合物(C)混合後,隨著時間經過,異氰酸酯化合物(C)加成於潛在性硬化劑(B)表面。因此,硬化性樹脂組成物中,隨著時間經過,潛在性硬化劑(B)之表面胺量減少。5. Status of latent hardener (B) and isocyanate compound (C) As described above, the curable resin composition is prepared by mixing the curable resin (A), the latent hardener (B) and the isocyanate compound (C) without reacting the latent hardener (B) and the isocyanate compound (C) in advance. ) are produced by mixing. When the curable resin (A), latent curing agent (B) and isocyanate compound (C) were mixed in this way, it was confirmed that the amount of surface amine groups of the latent curing agent (B) decreased. Here, the amount of surface amine groups refers to the amount of amine groups existing on the surface or surface layer of the granular latent hardener (B). Therefore, part or all of the latent hardener (B) reacts with part or all of the isocyanate compound (C). Preferably, all of the latent hardener (B) reacts with all of the isocyanate compound (C). For example, when the latent hardener (B) is fully reacted, the latent hardener (B) in the curable resin composition does not contain an unreacted state, but if it is confirmed that the latent hardener (B) and the isocyanate compound ( The reactant of C) becomes the curable resin composition of the present invention. When a part or all of the latent hardener (B) reacts with a part or all of the isocyanate compound (C), at least a part of the surface of the latent hardener (B) reacts with the isocyanate compound (C). That is, since the latent hardener (B) has a high reactivity with the isocyanate compound (C), it is considered that after the latent hardener (B) is mixed with the isocyanate compound (C), the isocyanate compound (C) Added to the surface of latent hardener (B). Therefore, in the curable resin composition, the amount of surface amines in the latent curing agent (B) decreases with the passage of time.
所謂潛在性硬化劑(B)與異氰酸酯化合物(C)反應之狀態推測係異氰酸酯化合物(C)中之反應異氰酸酯基與潛在性硬化劑(B)之1級胺基及/或2級胺基反應,形成脲鍵、縮二脲鍵或脲基甲酸酯(allophanate)鍵之狀態。The state of the reaction between the latent hardener (B) and the isocyanate compound (C) is presumed to be the reaction between the reactive isocyanate group in the isocyanate compound (C) and the primary amine group and/or secondary amine group of the latent hardener (B). , forming a state of urea bond, biuret bond or allophanate bond.
6.調配量 硬化性樹脂組成物相對於硬化性樹脂(A) 100質量份,潛在性硬化劑(B)較好包含1~100質量份,更好包含2~70質量份,又更好包含2~50質量份。且硬化性樹脂組成物相對於硬化性樹脂(A) 100質量份,異氰酸酯化合物(C)較好包含0.0002~28質量份,更好包含0.002~ 28質量份,又更好包含0.02~28質量份。若為此等調配比例,基於液安定性及組成物之硬化性的觀點係較佳。6. Deployment volume The curable resin composition preferably contains 1 to 100 parts by mass of the latent curing agent (B), more preferably 2 to 70 parts by mass, and more preferably 2 to 50 parts by mass, relative to 100 parts by mass of the curable resin (A). share. In addition, the curable resin composition preferably contains 0.0002 to 28 parts by mass, more preferably 0.002 to 28 parts by mass, and more preferably 0.02 to 28 parts by mass, relative to 100 parts by mass of the curable resin (A). . Such a blending ratio is preferable from the standpoint of liquid stability and hardening properties of the composition.
又,硬化性樹脂組成物相對於潛在性硬化劑(B) 100質量份,異氰酸酯化合物(C)較好包含0.02~28質量份,更好包含0.04~28質量份,又更好包含0.05~25質量份。若為此等調配比例,基於液安定性及組成物之硬化性的觀點係較佳。In addition, the curable resin composition preferably contains 0.02 to 28 parts by mass, more preferably 0.04 to 28 parts by mass, and more preferably 0.05 to 25 parts by mass of the isocyanate compound (C) relative to 100 parts by mass of the latent hardener (B). parts by mass. Such a blending ratio is preferable from the standpoint of liquid stability and hardening properties of the composition.
7.其他成分 硬化性樹脂組成物除了上述成分以外,較好包含光聚合起始劑(D)與其他根據需要之無機填充劑(E)、有機填充劑(F)、偶合劑(G)。7. Other ingredients The curable resin composition preferably contains a photopolymerization initiator (D), and other inorganic fillers (E), organic fillers (F), and coupling agents (G) as needed, in addition to the above components.
[光聚合起始劑(D)] 作為光聚合起始劑舉例為二苯甲酮、2,2-二乙氧基苯乙酮、聯苯醯、苯甲醯基異丙醚、苄基二甲基縮醛、1-羥基環己基苯基酮、噻噸酮等。且,作為光聚合起始劑,亦可使用市售之光自由基聚合起始劑。市售之光自由基聚合起始劑舉例為例如IRGACURE 907、IRGACURE 819、IRGACURE 651、IRGACURE 369、苯偶因甲醚、苯偶因乙醚、苯偶因異丙醚、LUCIRIN TPO(以上均為BASF JAPAN公司製)等。[Photopolymerization initiator (D)] Examples of photopolymerization initiators include benzophenone, 2,2-diethoxyacetophenone, diphenamide, benzoyl isopropyl ether, benzyl dimethyl acetal, 1-hydroxycyclohexyl Phenyl ketone, thioxanthone, etc. Moreover, a commercially available photoradical polymerization initiator can also be used as a photoinitiator. Commercially available photoradical polymerization initiators are, for example, IRGACURE 907, IRGACURE 819, IRGACURE 651, IRGACURE 369, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, LUCIRIN TPO (the above are BASF JAPAN Corporation), etc.
[無機填充劑(E)] 作為無機填充劑,並未特別限定,但舉例為例如球狀氧化矽、球狀氧化鋁、球狀氧化鈦、球狀氧化鋁、球狀碳酸鈣等。其中,基於分散性優異、適於液晶滴下法之密封劑的接著性、提高硬化物之耐濕性的效果優異,較好為球狀氧化矽。[Inorganic filler (E)] Although it does not specifically limit as an inorganic filler, For example, spherical silica, spherical alumina, spherical titanium oxide, spherical alumina, spherical calcium carbonate etc. are mentioned, for example. Among them, spherical silicon oxide is preferable because of excellent dispersibility, adhesiveness of a sealant suitable for the liquid crystal dropping method, and excellent effect of improving the moisture resistance of a cured product.
作為硬化性樹脂組成物之各成分的調配比例,相對於硬化性樹脂組成物100質量份,光聚合起始劑(D)較好為0.5~10質量份,更好為0.5~7質量份,又更好為0.8~4質量份。且,相對於硬化性樹脂組成物100質量份,無機填充劑(E)較好為0~40質量份,更好為2~30質量份,又更好為3~20質量份。且,液晶密封劑組成物之總質量中,(D)光聚合起始劑較好為0.5~3質量%。又,液晶密封劑組成物之總質量中,(E)無機填充劑較好為0~40質量%。The mixing ratio of each component of the curable resin composition is preferably 0.5 to 10 parts by mass, more preferably 0.5 to 7 parts by mass, of the photopolymerization initiator (D) relative to 100 parts by mass of the curable resin composition, More preferably, it is 0.8 to 4 parts by mass. And, with respect to 100 mass parts of curable resin compositions, the inorganic filler (E) is preferably 0-40 mass parts, more preferably 2-30 mass parts, still more preferably 3-20 mass parts. And, it is preferable that it is 0.5-3 mass % of (D) photoinitiators in the gross mass of a liquid crystal sealing compound composition. Moreover, it is preferable that it is 0-40 mass % of (E) inorganic filler in the gross mass of a liquid crystal sealing compound composition.
硬化性樹脂組成物較好特別留意無機填充劑等之固形物的均一、完全分散,而使用塗料輥等充分混練而製造。The curable resin composition is preferably prepared by kneading thoroughly with a coating roller, etc., paying special attention to the uniform and complete dispersion of solids such as inorganic fillers.
[有機填充劑(F)] 作為有機填充劑並未特別限定,舉例為例如單體或聚合物之微粒子,具體為聚酯微粒子、乙烯聚合物微粒子、丙烯酸聚合物微粒子、聚胺基甲酸酯微粒子。其中,基於透明性優異,較好為丙烯酸樹脂填料。[Organic filler (F)] The organic filler is not particularly limited, and examples thereof include fine particles of monomers or polymers, specifically polyester fine particles, vinyl polymer fine particles, acrylic polymer fine particles, and polyurethane fine particles. Among them, an acrylic resin filler is preferred because of its excellent transparency.
[偶合劑(G)] 作為偶合劑並未特別限定,舉例為例如矽烷偶合劑。[Coupling agent (G)] It does not specifically limit as a coupling agent, For example, a silane coupling agent is mentioned.
[其他成分] 硬化性樹脂組成物中,除上述樹脂以外,亦可根據需要含有矽氧樹脂、脲樹脂、醯亞胺樹脂、玻璃等。[other ingredients] The curable resin composition may contain silicone resin, urea resin, imide resin, glass, or the like as necessary, in addition to the above-mentioned resins.
又,硬化性樹脂組成物中,亦可根據需要調配作為各種添加劑之例如抗氧化劑、紫外線吸收劑、光安定劑、塗面改良劑、熱聚合抑制劑、調平劑、界面活性劑、著色劑、保存安定劑、可塑劑、滑劑、無機粒子、抗老化劑、濡濕性改良劑、抗靜電劑等。In addition, in the curable resin composition, various additives such as antioxidants, ultraviolet absorbers, light stabilizers, coating improvers, thermal polymerization inhibitors, leveling agents, surfactants, and colorants can also be formulated as needed. , Preservation stabilizers, plasticizers, slip agents, inorganic particles, anti-aging agents, wettability modifiers, antistatic agents, etc.
[液晶顯示面板] 硬化性樹脂組成物可滿足細線化及接著性之多樣化要求,同時可展現可抑制單元切出時及液晶驅動用之IC安裝時之剝落的接著強度,可較好地用於液晶顯示面板的製造。因此,硬化性樹脂組成物較好使用作為液晶顯示元件用密封劑組成物。且,液晶顯示面板具備對向的玻璃基板、將對向的玻璃基板接著之硬化性樹脂組成物的硬化物及以對向的玻璃基板及硬化性樹脂組成物的硬化物密封之液晶。[LCD panel] The curable resin composition can meet the diversification requirements for thinning lines and adhesiveness, and at the same time, it can exhibit the adhesive strength that can suppress peeling when cutting out the unit and installing the IC for liquid crystal driving, and can be better used for liquid crystal display panels manufacture. Therefore, it is preferable to use a curable resin composition as a sealing compound composition for liquid crystal display elements. In addition, the liquid crystal display panel includes an opposing glass substrate, a cured product of a curable resin composition adhering the opposing glass substrate, and a liquid crystal sealed with the opposing glass substrate and the cured product of the curable resin composition.
[液晶顯示面板之製造方法] 作為液晶顯示單元等之液晶顯示元件的製造方法之一已知有液晶滴下工法。液晶滴下工法係例如於一基板上形成液晶顯示元件用密封劑的框,於其中滴下液晶後,貼合另一基板,而將液晶密封製造液晶顯示元件之方法。最近,採用使用光熱併用型的硬化性樹脂組成物,以兩個基板夾住後,藉由作為第一階段之紫外線照射等使硬化性樹脂組成物光硬化,作為第二階段進行加熱硬化之方法。又,亦以檢討於滴下液晶後,僅藉由使硬化性樹脂組成物光硬化而製造液晶顯示單元之方法、僅藉熱硬化而製造液晶顯示單元之方法。 又,作為其他製造方法之一亦已知有液晶注入法。液晶注入法係例如在形成密封劑之框時設置成為液晶注入口的部分,貼合基材熱硬化後注入液晶,隨後以密封劑將該注入口封口進行光硬化而製造液晶顯示單元之方法。 硬化性樹脂組成物並非限定於上述工法,而可較好地廣泛用於液晶面板之製造方法。 [實施例][Manufacturing method of liquid crystal display panel] A liquid crystal dropping method is known as one of the methods of manufacturing liquid crystal display elements such as a liquid crystal display unit. The liquid crystal dropping method is, for example, a method of forming a sealant frame for a liquid crystal display element on a substrate, dropping liquid crystal therein, and bonding another substrate to seal the liquid crystal to manufacture a liquid crystal display element. Recently, a curable resin composition of a combination of light and heat has been used, and after sandwiching two substrates, the curable resin composition is photocured by ultraviolet irradiation as the first stage, and then heat-cured as the second stage. . Also, a method of manufacturing a liquid crystal display unit by only photocuring a curable resin composition after dropping a liquid crystal, and a method of manufacturing a liquid crystal display unit only by thermal curing are examined. Moreover, the liquid crystal injection method is also known as one of other manufacturing methods. The liquid crystal injection method is, for example, when forming the frame of the sealant, the part that will be the liquid crystal injection port is provided, the bonded base material is thermally cured, and the liquid crystal is injected, and then the injection port is sealed with the sealant for light curing to manufacture a liquid crystal display unit. The curable resin composition is not limited to the above-mentioned manufacturing method, but can be preferably widely used in the manufacturing method of liquid crystal panels. [Example]
[製造例1:1,1’-(己烷-1,6-二基)雙[3-(2-胺基乙基)脲](多元胺與異氰酸酯之加成物)(製造物1)之製造方法] [Production Example 1: 1,1'-(Hexane-1,6-diyl)bis[3-(2-Aminoethyl)urea] (Addition product of polyamine and isocyanate) (Production 1) manufacturing method]
準備於乙醇118g中溶解六亞甲基二異氰酸酯17.17g之溶解液A與於乙醇150g中溶解乙二胺61.36g之溶解液B。於三頸燒瓶中將溶解液B控制於25℃攪拌後,以1.4g/分鐘之步調滴下溶解液A。溶解液A滴下結束後,以傅理葉轉換紅外線分光光度計測定反應液,確認並無源自異氰酸酯基之2250cm-1 附近的波峰而結束反應。對於六亞甲基二異氰酸酯1莫耳反應乙二胺10莫耳(莫耳比為1:10)。 反應結束後,使用濾紙(桐山公司製No.4)以桐山漏斗(桐山公司製)過濾,進行脫液,所得濾取物以乙醇100ml洗淨,進行進一步過濾,以真空烘箱於50℃乾燥所得濾取物。乾燥後自然冷卻至室溫,以高壓粉碎機(商品名:Nano Jetmizer,AISHIN NANO TECHNOLOGY公司製)粉碎,製造平均粒徑(中值徑) 2.2μm之上述化學式(A-5)之多元胺與異氰酸酯化合物之加成物(以下亦稱為「製造物1」)。Solution A in which 17.17 g of hexamethylene diisocyanate was dissolved in 118 g of ethanol and solution B in which 61.36 g of ethylenediamine was dissolved in 150 g of ethanol were prepared. After the solution B was controlled at 25°C and stirred in the three-necked flask, the solution A was dropped at a rate of 1.4 g/min. After the solution A was dropped, the reaction solution was measured with a Fourier transform infrared spectrophotometer, and it was confirmed that there was no peak around 2250 cm -1 originating from the isocyanate group, and the reaction was terminated. For 1 mole of hexamethylene diisocyanate react 10 moles of ethylenediamine (the molar ratio is 1:10). After the reaction, use filter paper (No.4 manufactured by Kiriyama Co., Ltd.) to filter with a Kiriyama funnel (manufactured by Kiriyama Co., Ltd.) to remove the liquid. The obtained filtrate was washed with 100 ml of ethanol, further filtered, and dried in a vacuum oven at 50°C. Filtrate. Naturally cool to room temperature after drying, and pulverize with a high-pressure mill (trade name: Nano Jetmizer, manufactured by AISHIN NANO TECHNOLOGY Co., Ltd.) to produce the polyamine and Adduct product of isocyanate compound (hereinafter also referred to as "product 1").
[製造例2:多元胺與脲之加成物(製造物2)之製造方法] 於1L梨型燒瓶中饋入間-二甲苯二胺750g(5.5mol)與脲50g (0.832 mmol),於175℃攪拌5.5小時。隨後冷卻至室溫。添加THF(四氫呋喃)500ml並攪拌進行過濾。濾取物以THF 600ml攪拌洗淨,再度過濾。此處,於所得濾液中添加甲苯2000g,過濾所析出之結晶。所得濾取物於50℃真空乾燥者以高壓粉碎機(商品名:Nano Jetmizer,AISHIN NANO TECHNOLOGY公司製)粉碎,製造平均粒徑(中值徑)2.0μm之多元胺與脲之加成物(以下亦稱為「製造物2」)。[Production Example 2: Method for producing an adduct of polyamine and urea (Production 2)] 750 g (5.5 mol) of m-xylylenediamine and 50 g (0.832 mmol) of urea were fed into a 1 L pear-shaped flask, and stirred at 175° C. for 5.5 hours. Then cool to room temperature. 500 ml of THF (tetrahydrofuran) was added, stirred and filtered. The filtrate was stirred and washed with 600 ml of THF, and filtered again. Here, 2000 g of toluene was added to the obtained filtrate, and the precipitated crystal was filtered. The resulting filtrate was vacuum-dried at 50° C. and pulverized with a high-pressure mill (trade name: Nano Jetmizer, manufactured by AISHIN NANO TECHNOLOGY Co., Ltd.) to produce an adduct of polyamine and urea with an average particle diameter (median diameter) of 2.0 μm ( Hereinafter, it is also referred to as "manufacture 2").
[製造例3:4,4’-六亞甲基雙(半卡巴肼)(製造物3)之製造方法] [Production Example 3: Production method of 4,4'-hexamethylenebis(semicarbazide) (Production 3)]
準備於乙醇150g中溶解六亞甲基二異氰酸酯16.8g之溶解液A與於乙醇150g中溶解聯胺10g之溶解液B。將溶解液B控制於25℃攪拌後,以1.4g/分鐘之步調滴下溶解液A。溶解液A滴下結束後,以傅理葉轉換紅外線分光光度計測定反應液,確認並無源自異氰酸酯基之2250cm-1 附近的波峰而結束反應。對於六亞甲基二異氰酸酯1莫耳反應聯胺2莫耳(莫耳比為1:2)。 反應結束後,使用濾紙(桐山公司製No.4)以桐山漏斗(桐山公司製)過濾,進行脫液,所得濾取物以乙醇50ml洗淨,進行進一步過濾,以真空烘箱於50℃乾燥所得濾取物。乾燥後以高壓粉碎機(商品名:Nano Jetmizer,AISHIN NANO TECHNOLOGY公司製)粉碎,製造平均粒徑(中值徑) 2.1μm之上述化學式(B-2)表示之卡巴肼化合物(以下亦稱為「製造物3」)。Dissolution A in which 16.8 g of hexamethylene diisocyanate was dissolved in 150 g of ethanol and solution B in which 10 g of hydrazine was dissolved in 150 g of ethanol were prepared. After the solution B was stirred at 25°C, the solution A was dropped at a rate of 1.4 g/min. After the solution A was dropped, the reaction solution was measured with a Fourier transform infrared spectrophotometer, and it was confirmed that there was no peak around 2250 cm -1 originating from the isocyanate group, and the reaction was terminated. For 1 mole of hexamethylene diisocyanate, 2 moles of hydrazine are reacted (the molar ratio is 1:2). After the reaction, filter with a Kiriyama funnel (Kiriyama Co., Ltd. No. 4) using filter paper (Kiriyama Co., Ltd.) to remove the liquid. The obtained filtrate was washed with 50 ml of ethanol, further filtered, and dried in a vacuum oven at 50°C. Filtrate. After drying, pulverize with a high-pressure mill (trade name: Nano Jetmizer, manufactured by AISHIN NANO TECHNOLOGY Co., Ltd.) to produce a carbazide compound represented by the above chemical formula (B-2) with an average particle diameter (median diameter) of 2.1 μm (hereinafter also referred to as "Artifact 3").
[製造例4:2種以上之醯肼化合物之混合結晶(製造物4)之製造方法] 於5000ml之可分離燒瓶中饋入癸二酸二醯肼(SDH,大塚化學公司製) 500質量份、十二烷二酸二醯肼(DDH,大塚化學公司製) 500質量份、氧化鋁(AEROXIDE AluC,日本AEROSIL公司製) 50質量份(鋁含量為2.5質量%),於200℃加熱,獲得2種結晶性醯肼化合物大致成為液體狀態般溶解之混合物。該混合物於200℃進行2小時恆溫處理。 隨後,混合物移至預加熱至200℃之PYREX(註冊商標)製之玻璃盤中,設置於200℃之烘箱中。接著,熔融混合物於烘箱中,以1.0℃/分鐘左右之冷卻速度冷卻至室溫,獲得固化體。完全冷卻至室溫之固化體以切割研磨機(ORIENT公司製)粗粉碎,最終以高壓粉碎機(商品名:Nano Jetmizer,AISHIN NANO TECHNOLOGY公司製)粉碎,製造平均粒徑(中值徑) 2.5μm之醯肼化合物(以下亦稱為「製造物4」)。[Production Example 4: Method for producing mixed crystals of two or more hydrazine compounds (Production 4)] 500 parts by mass of dihydrazine sebacate (SDH, produced by Otsuka Chemical Co., Ltd.), 500 parts by mass of dihydrazide dodecanedioate (DDH, produced by Otsuka Chemical Co., Ltd.), aluminum oxide ( AEROXIDE AluC (manufactured by Japan Aerosil Co., Ltd.) 50 parts by mass (aluminum content: 2.5 mass%) was heated at 200° C. to obtain a mixture of two crystalline hydrazine compounds dissolved in a liquid state. The mixture was subjected to constant temperature treatment at 200°C for 2 hours. Then, the mixture was transferred to a glass dish made of PYREX (registered trademark) preheated to 200°C, and set in an oven at 200°C. Next, the molten mixture is cooled to room temperature in an oven at a cooling rate of about 1.0° C./minute to obtain a solidified body. The solidified body that was completely cooled to room temperature was coarsely pulverized with a cutting mill (manufactured by Orient Corporation), and finally pulverized with a high-pressure pulverizer (trade name: Nano Jetmizer, manufactured by AISHIN NANO TECHNOLOGY Co., Ltd.) to produce an average particle size (median diameter) of 2.5 The hydrazine compound of μm (hereinafter also referred to as "manufacture 4").
[實施例1] 調配部分甲基丙烯酸化雙酚A型環氧樹脂(KSM公司製,PR-850CRP) 100質量份、作為無機填充劑之氧化矽填料(日本觸媒公司製,SEAHOSTAR KE-C050HG) 10質量份、作為有機填充劑之丙烯酸樹脂填料(AICA工業公司製,F-351) 10質量份、光自由基起始劑(KSM公司製,EY RESIN KR-2) 2質量份及自由基聚合抑制劑(東京化成工業公司製,BHT:二丁基羥基甲苯) 0.15質量份與矽烷偶合劑(信越化學工業公司製,KBM-403) 1.0質量份、15質量份之作為潛在性硬化劑之製造例1所得之製造物1及作為異氰酸酯化合物之六亞甲基二異氰酸酯0.1質量份,於室溫(25℃)以三合一馬達(IKA公司製,商品名;RW28basic)均一分散獲得硬化性樹脂組成物。[Example 1] 100 parts by mass of partially methacrylated bisphenol A epoxy resin (manufactured by KSM, PR-850CRP), 10 parts by mass of silica filler (manufactured by Nippon Shokubai Co., Ltd., SEAHOSTAR KE-C050HG) as an inorganic filler, As an organic filler, 10 parts by mass of acrylic resin filler (manufactured by AICA Industry Co., Ltd., F-351), 2 parts by mass of a photoradical initiator (manufactured by KSM Corporation, EY RESIN KR-2), and a radical polymerization inhibitor (Tokyo Kasei Kogyo Co., Ltd., BHT (dibutylhydroxytoluene) 0.15 parts by mass and silane coupling agent (Shin-Etsu Chemical Co., Ltd., KBM-403) 1.0 parts by mass, 15 parts by mass obtained in Production Example 1 as a latent hardener Product 1 and 0.1 parts by mass of hexamethylene diisocyanate as an isocyanate compound were uniformly dispersed at room temperature (25° C.) with a three-in-one motor (manufactured by IKA, trade name; RW28basic) to obtain a curable resin composition.
[實施例2~41及比較例1~14] 除了硬化性樹脂組成物之調配設為表1~5之調配以外,與實施例1同樣,獲得硬化性樹脂組成物。 表中之簡寫如以下。 PR-850CRP:部分甲基丙烯酸化雙酚A型環氧樹脂(KSM公司製,製品名PR-850CRP) 850S:雙酚A型環氧樹脂(DIC公司製,製品名EPICLON 850S) KE-C050HG:氧化矽填料(日本觸媒公司製,SEAHOSTAR KE-C050HG) F-351:丙烯酸樹脂填料(AICA工業公司製,製品名F-351) KR-2:光自由基起始劑(KSM公司製,製品名EY RESIN KR-2) BHT:自由基聚合抑制劑二丁基羥基甲苯(東京化成工業公司製,製品名:BHT) KBM-403:矽烷偶合劑(信越化學工業公司製,製品名KBM-403) TPA-100:六亞甲基二異氰酸酯之聚異氰酸酯(旭化成公司製,製品名TPA-100) E402-100:六亞甲基二異氰酸酯之聚異氰酸酯(旭化成公司製,製品名E402-100) TSE-100:六亞甲基二異氰酸酯之聚異氰酸酯(旭化成公司製,製品名TSE-100) CURRANTS AOI:丙烯酸2-異氰酸酯基乙酯(昭和電工股份有限公司製,製品名CURRANTS AOI) EH-5057P:多元胺與環氧樹脂之加成物(ADEKA股份有限公司製,製品名EH-5057P) EH-5030S:多元胺與環氧樹脂之加成物(ADEKA股份有限公司製,製品名EH-5030S) FXR-1020:多元胺與環氧樹脂之加成物(T&K TOKA股份有限公司製,製品名FXR-1020) EH-5011S:咪唑與環氧樹脂之加成物(ADEKA股份有限公司製,製品名EH-5011S) EH-4070S:多元胺與環氧樹脂之加成物(ADEKA股份有限公司製,製品名EH-4070S) ADH:己二酸二醯肼(大塚化學股份有限公司製)[Examples 2-41 and Comparative Examples 1-14] A curable resin composition was obtained in the same manner as in Example 1 except that the preparation of the curable resin composition was the preparation of Tables 1 to 5. The abbreviations in the table are as follows. PR-850CRP: Partially methacrylated bisphenol A epoxy resin (manufactured by KSM, product name PR-850CRP) 850S: Bisphenol A type epoxy resin (manufactured by DIC Corporation, product name EPICLON 850S) KE-C050HG: Silicon oxide filler (manufactured by Nippon Shokubai Co., Ltd., SEAHOSTAR KE-C050HG) F-351: Acrylic resin filler (manufactured by AICA Industry Co., Ltd., product name F-351) KR-2: photoradical initiator (manufactured by KSM Corporation, product name EY RESIN KR-2) BHT: radical polymerization inhibitor dibutylhydroxytoluene (manufactured by Tokyo Chemical Industry Co., Ltd., product name: BHT) KBM-403: Silane coupling agent (manufactured by Shin-Etsu Chemical Co., Ltd., product name KBM-403) TPA-100: polyisocyanate of hexamethylene diisocyanate (manufactured by Asahi Kasei Co., Ltd., product name TPA-100) E402-100: Polyisocyanate of hexamethylene diisocyanate (manufactured by Asahi Kasei Co., Ltd., product name E402-100) TSE-100: Polyisocyanate of hexamethylene diisocyanate (manufactured by Asahi Kasei Co., Ltd., product name TSE-100) CURRANTS AOI: 2-isocyanatoethyl acrylate (manufactured by Showa Denko Co., Ltd., product name CURRANTS AOI) EH-5057P: Adduct of polyamine and epoxy resin (manufactured by ADEKA Co., Ltd., product name EH-5057P) EH-5030S: Adduct of polyamine and epoxy resin (manufactured by ADEKA Co., Ltd., product name EH-5030S) FXR-1020: Adduct of polyamine and epoxy resin (manufactured by T&K TOKA Co., Ltd., product name FXR-1020) EH-5011S: Adduct of imidazole and epoxy resin (manufactured by ADEKA Co., Ltd., product name EH-5011S) EH-4070S: Adduct of polyamine and epoxy resin (manufactured by ADEKA Co., Ltd., product name EH-4070S) ADH: Dihydrazine adipate (manufactured by Otsuka Chemical Co., Ltd.)
[評價] (室溫保存安定性) 測定實施例及比較例之樹脂組成物剛調製後之黏度(2小時以內)作為初期黏度。進而分別測定將實施例及比較例之樹脂組成物於25℃放置7天後之黏度及於25℃放置14天後之黏度,以初期黏度為基準,算出黏度變化率(%)。 又,黏度係如下般測定。於RE-105U型黏度計(東機產業公司製)上安裝3°×R7.7錐形轉子,將成為對象之樹脂組成物0.15ml設定於錐形轉子內,以2.5rpm測定於25℃之樹脂組成物黏度。於超過測定範圍時稱為無法測定。又,超過測定範圍之基準係1,200,000mPa・s。[evaluate] (storage stability at room temperature) The viscosity (within 2 hours) immediately after preparation of the resin compositions of Examples and Comparative Examples was measured as the initial viscosity. Furthermore, the viscosities of the resin compositions of Examples and Comparative Examples after being placed at 25°C for 7 days and after being placed at 25°C for 14 days were respectively measured, and the viscosity change rate (%) was calculated based on the initial viscosity. In addition, the viscosity was measured as follows. Install a 3°×R7.7 conical rotor on the RE-105U viscometer (manufactured by Toki Sangyo Co., Ltd.), set 0.15ml of the target resin composition in the conical rotor, and measure at 25°C at 2.5rpm The viscosity of the resin composition. When it exceeds the measuring range, it is called unmeasurable. Also, the standard beyond the measurement range is 1,200,000 mPa·s.
(加溫保存安定性) (1) 40℃加溫後保存安定性 測定實施例及比較例之樹脂組成物剛調製後之黏度(2小時以內)作為初期黏度。隨後測定將實施例及比較例之樹脂組成物於40℃加溫2小時後之黏度,進而分別測定於25℃放置7天後之黏度及於25℃放置14天後之黏度,以初期黏度為基準,算出黏度變化率(%)。(heating storage stability) (1) Storage stability after heating at 40°C The viscosity (within 2 hours) immediately after preparation of the resin compositions of Examples and Comparative Examples was measured as the initial viscosity. Then measure the viscosity of the resin composition of the example and the comparative example after heating at 40°C for 2 hours, and then measure the viscosity after standing at 25°C for 7 days and the viscosity after standing at 25°C for 14 days, the initial viscosity is Calculate the viscosity change rate (%).
(2) 50℃加溫後保存安定性 測定實施例及比較例之樹脂組成物剛調製後之黏度(2小時以內)作為初期黏度。隨後測定將實施例及比較例之樹脂組成物於50℃加溫2小時後之黏度,進而分別測定於25℃放置7天後之黏度及於25℃放置14天後之黏度,以初期黏度為基準,算出黏度變化率(%)。 又,黏度係與液安定性評價同樣測定。(2) Storage stability after heating at 50°C The viscosity (within 2 hours) immediately after preparation of the resin compositions of Examples and Comparative Examples was measured as the initial viscosity. Then measure the viscosity of the resin compositions of Examples and Comparative Examples after heating at 50°C for 2 hours, and then measure the viscosity after standing at 25°C for 7 days and the viscosity after standing at 25°C for 14 days, the initial viscosity is Calculate the viscosity change rate (%). In addition, the viscosity system was measured in the same manner as the liquid stability evaluation.
(硬化性試驗) 針對實施例及比較例之樹脂組成物分別於1) 於120℃硬化處理1小時之情況,及2) 經UV3000mJ/cm2 處理後於120℃硬化處理1小時之情況的硬化片,藉以下方法評價硬化性。(Curability Test) For the resin compositions of Examples and Comparative Examples, 1) curing treatment at 120°C for 1 hour, and 2) curing at 120°C for 1 hour after UV3000mJ/ cm2 treatment Tablets were evaluated for curability by the following method.
以上述條件硬化所得之各硬化片利用FT-IR測定裝置(Spectrum one,Perkin Elmer公司製)測定,進行硬化性評價。環氧硬化率之算出方法使用以下式。式中,所謂樹脂組成物為未硬化物。未添加異氰酸酯之樹脂組成物作為空白組,與空白組之差以○×進行評價。Each cured sheet obtained by curing under the above-mentioned conditions was measured by an FT-IR measuring device (Spectrum one, manufactured by Perkin Elmer Co., Ltd.), and curability was evaluated. The calculation method of the epoxy hardening rate used the following formula. In the formula, the resin composition is an uncured product. The resin composition without adding isocyanate was used as a blank group, and the difference with the blank group was evaluated by ○×.
基準波峰之存在區域;1540~1480cm-1 (峰頂1510cm-1 附近) 環氧基之波峰存在區域;925~895cm-1 (峰頂910cm-1 附近) ○:硬化率相對於空白組為0~-20% ×:硬化率相對於空白組為未達-20%Existence area of reference peak; 1540~1480cm -1 (near peak 1510cm -1 ) Existence area of epoxy group peak: 925~895cm -1 (near peak 910cm -1 ) ○: Curing rate is 0 compared to blank group ~-20% ×: The hardening rate is less than -20% compared to the blank group
(丙酮洗淨性試驗) 以1ml TERUMO針筒取未硬化之實施例及比較例的樹脂組成物0.1ml,於玻璃板上塗佈為線狀2cm。於300ml燒杯中放入丙酮200ml,於其中,以使塗佈於載玻片之組成物浸漬之方式立起。靜置5分鐘後,以超音波洗淨裝置(裝置名;SND股份有限公司製US-20PS)洗淨5分鐘,隨後將玻璃板自丙酮浴取出,使目視觀察玻璃狀態,藉以下基準進行評價。 ×:樹脂組成物殘留。 ○:樹脂組成物未殘留。(Acetone detergency test) Use a 1ml TERUMO syringe to take 0.1ml of the unhardened resin composition of Examples and Comparative Examples, and spread it on a glass plate in a linear shape of 2cm. 200 ml of acetone was put into a 300 ml beaker, and stood up so that the composition coated on the glass slide would be immersed therein. After standing still for 5 minutes, clean the glass plate with an ultrasonic cleaning device (device name; US-20PS manufactured by SND Co., Ltd.) for 5 minutes, then take the glass plate out of the acetone bath, observe the state of the glass visually, and use the following criteria to evaluate . ×: The resin composition remains. ◯: The resin composition does not remain.
由上述結果可知,本發明之硬化性樹脂組成物係硬化性良好,相較於不含異氰酸酯化合物之比較例,液安定性及丙酮洗淨性較優異。且,相較於使用醯肼系硬化劑作為潛在性硬化劑之比較例9~12,硬化性優異或液安定性優異。From the above results, it can be seen that the curable resin composition of the present invention has good curability, and is superior in liquid stability and acetone cleaning performance compared with the comparative example not containing isocyanate compounds. Furthermore, compared with Comparative Examples 9 to 12 in which a hydrazine-based curing agent was used as a latent curing agent, they were excellent in curability or excellent in liquid stability.
(表面胺量) 實施例41之硬化性樹脂組成物5.75質量份與比較例14之硬化性樹脂組成物5.75質量份分別溶解於丙腈20質量份中,使用1μm膜過濾器進行抽吸過濾,進而以乙腈15質量份沖洗進行洗淨。濾取物於25真空乾燥,自實施例41獲得者設為處理物1,自比較例14所得者設為處理物2。 處理物1及2分別採取0.05質量份於個別安瓿中,添加20質量份之以甲基環己烷將異氰酸苯酯調整為20ppm之溶液。 放入超音波洗淨槽(NSD股份有限公司製US-20PS),邊施加超音波邊分散3分鐘。此時以手振動安瓿予以分散。隨後於70℃熱水浴中浸入1小時。每20分鐘以手振動安瓿。於70℃熱水浴中浸入1小時結束後,放入超音波洗淨槽,邊施加超音波邊以手振動安瓿3分鐘予以分散。 冷卻至室溫後上澄液取入針筒中,以PTET製0.2μm過濾器過濾之濾液以分光光度計(日本分光股份有限公司製V-570)測定吸光度。空白組設為甲基環己烷,讀取20ppm異氰酸苯酯-甲基環己烷溶液與各樣品之226nm的吸光度。使用事先作成之異氰酸苯酯校正線算出異氰酸苯酯濃度,自濃度減少量算出製造物1及處理物1每1g之表面胺基量(mmol),作為表面胺量。 其結果可知,處理物2之表面胺量0.77mmol/g,處理物1的表面胺量為0.10mmol/g。 由其結果,由包含潛在性硬化劑(B)及異氰酸酯化合物(C)之實施例41所得之處理物1,相較於未含異氰酸酯化合物(C)之比較例14所得之處理物2,表面胺量相當減少。因此,確認藉由混合硬化性樹脂(A)、潛在性硬化劑(B)及異氰酸酯化合物(C),使潛在性硬化劑(B)之一部分或全部與異氰酸酯化合物(C)之一部分或全部進行反應,同時確認潛在性硬化劑(B)之表面胺量減少。進行該等之液安定性評價。結果示於表5。(Amount of surface amine) 5.75 parts by mass of the curable resin composition of Example 41 and 5.75 parts by mass of the curable resin composition of Comparative Example 14 were respectively dissolved in 20 parts by mass of propionitrile, suction filtered using a 1 μm membrane filter, and then 15 parts by mass of acetonitrile Rinse to clean. The filtrate was vacuum-dried at 25°C, and the obtained product from Example 41 was set as the treated product 1, and the obtained product from Comparative Example 14 was set as the processed product 2. 0.05 parts by mass of treated substances 1 and 2 were put into individual ampoules, and 20 parts by mass of a solution adjusted to 20 ppm of phenyl isocyanate with methylcyclohexane was added. Put in an ultrasonic cleaning tank (US-20PS manufactured by NSD Co., Ltd.), and disperse for 3 minutes while applying ultrasonic waves. At this point, shake the ampoule by hand to disperse. Subsequent immersion in a 70° C. hot water bath for 1 hour. Shake the ampoule by hand every 20 minutes. After immersing in a hot water bath at 70°C for 1 hour, put it into an ultrasonic cleaning tank, and shake the ampoule by hand for 3 minutes while applying ultrasonic waves to disperse. After cooling to room temperature, the supernatant liquid was taken into a syringe, and the filtrate was filtered with a 0.2 μm filter made of PTET to measure the absorbance with a spectrophotometer (V-570 manufactured by JASCO Co., Ltd.). The blank group was set as methylcyclohexane, and the absorbance at 226nm of 20ppm phenylisocyanate-methylcyclohexane solution and each sample was read. The phenyl isocyanate concentration was calculated using the phenyl isocyanate calibration line prepared in advance, and the amount of surface amine groups (mmol) per 1 g of the manufactured product 1 and the processed product 1 was calculated from the concentration decrease as the surface amine amount. As a result, it was found that the surface amine amount of the treated object 2 was 0.77 mmol/g, and the surface amine amount of the processed object 1 was 0.10 mmol/g. As a result, the treated product 1 obtained in Example 41 containing the latent hardener (B) and the isocyanate compound (C) was compared to the processed product 2 obtained in Comparative Example 14 that did not contain the isocyanate compound (C). The amount of amine is considerably reduced. Therefore, it was confirmed that by mixing the curable resin (A), the latent hardener (B) and the isocyanate compound (C), a part or all of the latent hardener (B) was mixed with a part or all of the isocyanate compound (C). Reaction, while confirming that the surface amine amount of the latent hardener (B) is reduced. Conduct such liquid stability evaluations. The results are shown in Table 5.
[產業上之可利用性] [Industrial availability]
本發明之硬化性樹脂組成物可較好地使用作為例如液晶顯示面板等之電子零件之密封劑或封止劑,於產業上有用。The curable resin composition of the present invention can be preferably used as a sealant or sealing agent for electronic parts such as liquid crystal display panels, and is industrially useful.
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-228924 | 2017-11-29 | ||
JP2017228924 | 2017-11-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201932528A TW201932528A (en) | 2019-08-16 |
TWI805645B true TWI805645B (en) | 2023-06-21 |
Family
ID=66664478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107140140A TWI805645B (en) | 2017-11-29 | 2018-11-13 | Curable resin composition and manufacturing method thereof |
Country Status (5)
Country | Link |
---|---|
JP (2) | JPWO2019107070A1 (en) |
KR (1) | KR102594919B1 (en) |
CN (1) | CN111344330A (en) |
TW (1) | TWI805645B (en) |
WO (1) | WO2019107070A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6650151B2 (en) * | 2018-04-03 | 2020-02-19 | 協立化学産業株式会社 | Curable composition, liquid crystal panel, and method of manufacturing liquid crystal panel |
JP7151003B2 (en) * | 2020-09-30 | 2022-10-11 | 積水化学工業株式会社 | Sealant for liquid crystal dropping method, vertical conduction material, and liquid crystal display element |
JP7432492B2 (en) | 2020-12-11 | 2024-02-16 | 日本化薬株式会社 | Liquid crystal sealant for liquid crystal dripping method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013095795A (en) * | 2011-10-28 | 2013-05-20 | Kyoritsu Kagaku Sangyo Kk | Dripping sealing agent composition |
CN103261284A (en) * | 2010-12-17 | 2013-08-21 | Adeka株式会社 | Masterbatch-type latent curing agent for epoxy resin, and epoxy resin composition using the same |
TW201418344A (en) * | 2012-07-11 | 2014-05-16 | Kyoritsu Chemical & Co Ltd | Curing agent and resin composition using same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5324014B2 (en) * | 1973-09-08 | 1978-07-18 | ||
US4635054A (en) * | 1985-07-10 | 1987-01-06 | Light Signatures, Inc. | Operator interactive device verification system |
JPH0551432A (en) * | 1990-07-05 | 1993-03-02 | Dainippon Ink & Chem Inc | Production of thermosetting resin composition and laminated sheet |
JPH0578445A (en) * | 1991-09-25 | 1993-03-30 | Sumitomo Chem Co Ltd | Epoxy resin composition |
JP3367531B2 (en) * | 1992-10-22 | 2003-01-14 | 味の素株式会社 | Epoxy resin composition |
JPH09249730A (en) * | 1996-03-14 | 1997-09-22 | Nitto Denko Corp | Thermosetting foam and use thereof |
JP3583326B2 (en) | 1999-11-01 | 2004-11-04 | 協立化学産業株式会社 | Sealant for dripping method of LCD panel |
JP2006323039A (en) * | 2005-05-18 | 2006-11-30 | Shin Etsu Chem Co Ltd | Sealing agent composition for liquid crystal display element |
JP4911981B2 (en) * | 2006-02-03 | 2012-04-04 | 旭化成イーマテリアルズ株式会社 | Curing agent for highly water-containing solvent-containing epoxy resin and epoxy resin composition |
JP5475223B2 (en) * | 2007-10-09 | 2014-04-16 | 株式会社Adeka | One-component cyanate-epoxy composite resin composition, cured product thereof and method for producing the same, and sealing material and adhesive using the same |
JP5139231B2 (en) | 2008-10-09 | 2013-02-06 | 株式会社Adeka | Method for producing latent curing agent for powdery epoxy resin, latent curing agent for powdery epoxy resin obtained by the method, and curable epoxy resin composition comprising the latent curing agent for powdery epoxy resin object |
KR101493625B1 (en) * | 2010-09-15 | 2015-02-23 | 닛뽕소다 가부시키가이샤 | Liquid curable epoxy resin composition and adhesive agent containing same |
JP2012093582A (en) | 2010-10-27 | 2012-05-17 | Sekisui Chem Co Ltd | Sealant for liquid crystal one-drop-fill process |
-
2018
- 2018-11-02 CN CN201880073520.1A patent/CN111344330A/en active Pending
- 2018-11-02 WO PCT/JP2018/040817 patent/WO2019107070A1/en active Application Filing
- 2018-11-02 JP JP2019557091A patent/JPWO2019107070A1/en active Pending
- 2018-11-02 KR KR1020207015742A patent/KR102594919B1/en active IP Right Grant
- 2018-11-13 TW TW107140140A patent/TWI805645B/en active
-
2022
- 2022-05-02 JP JP2022075865A patent/JP7297338B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103261284A (en) * | 2010-12-17 | 2013-08-21 | Adeka株式会社 | Masterbatch-type latent curing agent for epoxy resin, and epoxy resin composition using the same |
JP2013095795A (en) * | 2011-10-28 | 2013-05-20 | Kyoritsu Kagaku Sangyo Kk | Dripping sealing agent composition |
TW201418344A (en) * | 2012-07-11 | 2014-05-16 | Kyoritsu Chemical & Co Ltd | Curing agent and resin composition using same |
Also Published As
Publication number | Publication date |
---|---|
JP2022105144A (en) | 2022-07-12 |
KR102594919B1 (en) | 2023-10-27 |
JP7297338B2 (en) | 2023-06-26 |
KR20200083556A (en) | 2020-07-08 |
WO2019107070A1 (en) | 2019-06-06 |
JPWO2019107070A1 (en) | 2020-12-24 |
CN111344330A (en) | 2020-06-26 |
TW201932528A (en) | 2019-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7297338B2 (en) | Curable resin composition and method for producing the same | |
KR100662176B1 (en) | Anisotropic conductive film composition | |
KR101795127B1 (en) | Curable electroconductive adhesive composition, electromagnetic shielding film, electroconductive adhesive film, adhesion method, and circuit board | |
JP4862921B2 (en) | Circuit connection material, circuit connection structure and manufacturing method thereof | |
TWI672335B (en) | Resin composition, adhesive agent and sealant | |
JP6873489B2 (en) | Resin compositions, adhesives, encapsulants, dams, and semiconductor devices | |
US8067484B2 (en) | Latent hardener with improved barrier properties and compatibility | |
TW201204797A (en) | Adhesive composition, connecting structure and fabricating method thereof, and use of adhesive composition | |
JP6048717B2 (en) | Drip sealant composition | |
KR20200072358A (en) | Two part adhesive composition and cured product thereof and vehicle material adhesive method | |
JP6702534B2 (en) | Epoxy resin composition | |
KR20190022507A (en) | Thermosetting conductive adhesive | |
TW202309233A (en) | Resin composition and adhesive | |
TW201704433A (en) | Adhesive composition and connected structure | |
JP7474495B2 (en) | Composition for liquid crystal sealant and use thereof | |
JP5263521B2 (en) | Curable resin composition | |
JP2008144021A (en) | Adhesive for joining semiconductor chip | |
WO2017078157A1 (en) | Adhesive composition and structure | |
WO2022145362A1 (en) | Aqueous dispersion liquid, adhesive agent composition, adhesive agent, affixing material, and adhesive tape | |
JP2015151536A (en) | Adhesive composition and connection structure | |
JP2013185124A (en) | Interlayer filler composition for three-dimensional integrated circuit, coating liquid, and method for producing the three-dimensional integrated circuit | |
TWI844802B (en) | Adhesive composition and connecting structure | |
JP2020143237A (en) | Adhesive composition | |
JP2024089740A (en) | Urethane urea resin, and resin composition containing the same | |
JP2012012518A (en) | Epoxy resin composition |